Comparative Gene Ontology Analysis of Scleroderma and Normal Fibroblasts:
Number of investigated GO categories: 1297
Random variance model was used
GO categories which discriminate among classes:
Table – Sorted by p-value of the LS permutation test.
The first 35 GO categories are significant at the nominal 0.01 level of the LS permutation test or KS permutation test
GO category | GO description | Number of genes | LS Permutation p-value | KS Permutation p-value | |
---|---|---|---|---|---|
1 | 0016628 | oxidoreductase activity\, acting on the CH-CH group of donors\, NAD or NADP as acceptor |
8 | 1e-05 | 0.00018 |
2 | 0006958 | complement activation\, classical pathway | 13 | 0.00113 | 0.08394 |
3 | 0006672 | ceramide metabolism | 7 | 0.00166 | 0.00067 |
4 | 0004030 | aldehyde dehydrogenase [NAD(P)+] activity | 5 | 0.00245 | 0.00549 |
5 | 0006692 | prostanoid metabolism | 5 | 0.00252 | 0.01296 |
6 | 0006693 | prostaglandin metabolism | 5 | 0.00252 | 0.01296 |
7 | 0004867 | serine-type endopeptidase inhibitor activity | 23 | 0.00345 | 0.0486 |
8 | 0016477 | cell migration | 26 | 0.00361 | 0.00642 |
9 | 0030934 | anchoring collagen | 6 | 0.00387 | 0.51802 |
10 | 0005201 | extracellular matrix structural constituent | 40 | 0.00405 | 0.09777 |
11 | 0006956 | complement activation | 16 | 0.00475 | 0.2066 |
12 | 0046519 | sphingoid metabolism | 9 | 0.00481 | 0.01755 |
13 | 0000323 | lytic vacuole | 54 | 0.00486 | 0.02689 |
14 | 0005764 | lysosome | 54 | 0.00486 | 0.02689 |
15 | 0005773 | vacuole | 54 | 0.00486 | 0.02689 |
16 | 0006690 | icosanoid metabolism | 11 | 0.0055 | 0.02742 |
17 | 0006000 | fructose metabolism | 8 | 0.00623 | 0.20487 |
18 | 0009986 | cell surface | 7 | 0.00643 | 0.35003 |
19 | 0007411 | axon guidance | 9 | 0.00695 | 0.24773 |
20 | 0006665 | sphingolipid metabolism | 17 | 0.00769 | 0.00484 |
21 | 0004028 | aldehyde dehydrogenase activity | 9 | 0.0084 | 0.06054 |
22 | 0005581 | collagen | 20 | 0.00911 | 0.49494 |
23 | 0045664 | regulation of neuron differentiation | 5 | 0.00918 | 0.34871 |
24 | 0051094 | positive regulation of development | 5 | 0.00959 | 0.33501 |
25 | 0045597 | positive regulation of cell differentiation | 5 | 0.00959 | 0.33501 |
26 | 0008154 | actin polymerization and/or depolymerization | 8 | 0.01866 | 0.00857 |
27 | 0008645 | hexose transport | 7 | 0.02172 | 0.00039 |
28 | 0015749 | monosaccharide transport | 7 | 0.02172 | 0.00039 |
29 | 0015758 | glucose transport | 7 | 0.02172 | 0.00039 |
30 | 0001871 | pattern binding | 40 | 0.02237 | 0.00552 |
31 | 0005087 | Ran guanyl nucleotide exchange factor activity | 5 | 0.02321 | 0.00157 |
32 | 0030246 | carbohydrate binding | 71 | 0.04249 | 0.00809 |
33 | 0030166 | proteoglycan biosynthesis | 5 | 0.09002 | 0.0035 |
34 | 0008047 | enzyme activator activity | 81 | 0.11346 | 0.00602 |
35 | 0015078 | hydrogen ion transporter activity | 73 | 0.29583 | 0.00747 |
Table Significant GO categories consist of the following genes:
GO category | GO description | Qiagen oligo ID | Description | GB acc | UG cluster | Gene symbol | Geometric mean of ratios (Disease / Normal) | p-value | |
---|---|---|---|---|---|---|---|---|---|
1 | 0016628 | oxidoreductase activity\, acting on the CH-CH group of donors\, NAD or NADP as acceptor |
H001509_01 | Aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) |
D17793 | 78183 | AKR1C3 | 0.465 | 3e-05 |
2 | 0016628 | oxidoreductase activity\, acting on the CH-CH group of donors\, NAD or NADP as acceptor | H002522_01 | Dihydropyrimidine dehydrogenase | U20938 | 1602 | DPYD | 0.866 | 0.08026 |
3 | 0016628 | oxidoreductase activity\, acting on the CH-CH group of donors\, NAD or NADP as acceptor |
H002933_01 | Biliverdin reductase B (flavin reductase (NADPH)) | D32143 | 76289 | BLVRB | 0.915 | 0.11985 |
4 | 0016628 | oxidoreductase activity\, acting on the CH-CH group of donors\, NAD or NADP as acceptor |
H003233_01 | Biliverdin reductase A | X93086 | 81029 | BLVRA | 0.909 | 0.06164 |
5 | 0016628 | oxidoreductase activity\, acting on the CH-CH group of donors\, NAD or NADP as acceptor |
H003858_01 | Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-a |
U05598 | 201967 | AKR1C2 | 0.517 | 4e-05 |
6 | 0016628 | oxidoreductase activity\, acting on the CH-CH group of donors\, NAD or NADP as acceptor |
H007766_01 | Transmembrane 7 superfamily member 2 | AF023676 | 31130 | TM7SF2 | 0.85 | 0.04199 |
7 | 0016628 | oxidoreductase activity\, acting on the CH-CH group of donors\, NAD or NADP as acceptor |
H000726_01 | 7-dehydrocholesterol reductase | AF034544 | 11806 | DHCR7 | 0.94 | 0.38822 |
8 | 0016628 | oxidoreductase activity\, acting on the CH-CH group of donors\, NAD or NADP as acceptor |
H014963_01 | Peroxisomal trans 2-enoyl CoA reductase; putative short chain alcohol dehydrogenase |
AF119841 | 281680 | HSA250303 | 1.096 | 0.09119 |
9 | 0006958 | complement activation\, classical pathway | H002203_01 | Complement component 4-binding protein, alpha | M31452 | 1012 | C4BPA | 0.981 | 0.7132 |
10 | 0006958 | complement activation\, classical pathway | H002407_01 | I factor (complement) | Y00318 | 36602 | IF | 0.87 | 0.08583 |
11 | 0006958 | complement activation\, classical pathway | H002469_01 | Complement component 3 | K02765 | 284394 | C3 | 1.036 | 0.66839 |
12 | 0006958 | complement activation\, classical pathway | H002497_01 | Complement component 1, r subcomponent | M14058 | 1279 | C1R | 0.684 | 0.00136 |
13 | 0006958 | complement activation\, classical pathway | H002515_01 | Clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed pro |
M25915 | 75106 | CLU | 0.91 | 0.46421 |
14 | 0006958 | complement activation\, classical pathway | H002605_01 | Mannan-binding lectin serine protease 2 | X98400 | 119983 | MASP2 | 1.039 | 0.55015 |
15 | 0006958 | complement activation\, classical pathway | H002805_01 | Membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen) |
X59405 | 83532 | MCP | 0.784 | 0.0075 |
16 | 0006958 | complement activation\, classical pathway | H002996_01 | Complement component (3d/Epstein Barr virus) receptor 2 | J03565 | 73792 | CR2 | 0.978 | 0.81221 |
17 | 0006958 | complement activation\, classical pathway | H003011_01 | Complement component 1, s subcomponent | J04080 | 169756 | C1S | 0.811 | 0.02135 |
18 | 0006958 | complement activation\, classical pathway | H003528_01 | Decay accelerating factor for complement (CD55, Cromer blood group system) |
M30142 | 1369 | DAF | 0.621 | 0 |
19 | 0006958 | complement activation\, classical pathway | H011506_01 | Homo sapiens mRNA; cDNA DKFZp586F0824 (from clone DKFZp586F0824); partial cds |
AL137646 | 146001 | 0.794 | 0.05535 | |
20 | 0006958 | complement activation\, classical pathway | H001027_01 | Complement component 8, alpha polypeptide | M16974 | 93210 | C8A | 0.954 | 0.48929 |
21 | 0006958 | complement activation\, classical pathway | H001061_01 | Complement component 4A | K02403 | 170250 | C4A | 1.04 | 0.62746 |
22 | 0006672 | ceramide metabolism | H000025_01 | Neutral sphingomyelinase (N-SMase) activation associated factor |
X96586 | 78687 | NSMAF | 0.742 | 0.00058 |
23 | 0006672 | ceramide metabolism | H004193_01 | Sialyltransferase 9 (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase; GM3 synthase) |
AB018356 | 225939 | SIAT9 | 0.814 | 0.06525 |
24 | 0006672 | ceramide metabolism | H000464_01 | Protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform |
M65254 | 108705 | PPP2R1B | 0.937 | 0.24318 |
25 | 0006672 | ceramide metabolism | H008553_01 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | AB022017 | 9247 | PRKAA1 | 1.089 | 0.15692 |
26 | 0006672 | ceramide metabolism | H000076_01 | UDP-glucose ceramide glucosyltransferase | D50840 | 152601 | UGCG | 0.81 | 0.01527 |
27 | 0006672 | ceramide metabolism | H001062_01 | N-acylsphingosine amidohydrolase (acid ceramidase) | U70063 | 75811 | ASAH | 0.761 | 0.00155 |
28 | 0006672 | ceramide metabolism | H001148_01 | Galactosylceramidase (Krabbe disease) | NM_000153 | 273 | GALC | 0.883 | 0.0751 |
29 | 0004030 | aldehyde dehydrogenase [NAD(P)+] activity | H001547_01 | Aldehyde dehydrogenase 3 family, member A1 | M74542 | 575 | ALDH3A1 | 1.208 | 0.02494 |
30 | 0004030 | aldehyde dehydrogenase [NAD(P)+] activity | H001572_01 | Aldehyde dehydrogenase 3 family, member B2 | U37519 | 87539 | ALDH3B2 | 1.047 | 0.51127 |
31 | 0004030 | aldehyde dehydrogenase [NAD(P)+] activity | H002609_01 | Aldehyde dehydrogenase 3 family, member B1 | U10868 | 83155 | ALDH3B1 | 0.893 | 0.05664 |
32 | 0004030 | aldehyde dehydrogenase [NAD(P)+] activity | H003022_01 | Aldehyde dehydrogenase 1 family, member A3 | U07919 | 75746 | ALDH1A3 | 0.641 | 0.01304 |
33 | 0004030 | aldehyde dehydrogenase [NAD(P)+] activity | H003776_01 | Aldehyde dehydrogenase 2 family (mitochondrial) | X05409 | 195432 | ALDH2 | 1.249 | 7e-05 |
34 | 0006692 | prostanoid metabolism | H001509_01 | Aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) |
D17793 | 78183 | AKR1C3 | 0.465 | 3e-05 |
35 | 0006692 | prostanoid metabolism | H001562_01 | Hydroxyprostaglandin dehydrogenase 15-(NAD) | L76465 | 77348 | HPGD | 1.042 | 0.50286 |
36 | 0006692 | prostanoid metabolism | H001846_01 | Unactive progesterone receptor, 23 kD | L24804 | 278270 | P23 | 0.825 | 0.05398 |
37 | 0006692 | prostanoid metabolism | H003299_01 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
M59979 | 88474 | PTGS1 | 1.394 | 0.00734 |
38 | 0006692 | prostanoid metabolism | H006848_01 | Prostaglandin D2 synthase (21kD, brain) | NM_000954 | 8272 | PTGDS | 0.872 | 0.10275 |
39 | 0006693 | prostaglandin metabolism | H001509_01 | Aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) |
D17793 | 78183 | AKR1C3 | 0.465 | 3e-05 |
40 | 0006693 | prostaglandin metabolism | H001562_01 | Hydroxyprostaglandin dehydrogenase 15-(NAD) | L76465 | 77348 | HPGD | 1.042 | 0.50286 |
41 | 0006693 | prostaglandin metabolism | H001846_01 | Unactive progesterone receptor, 23 kD | L24804 | 278270 | P23 | 0.825 | 0.05398 |
42 | 0006693 | prostaglandin metabolism | H003299_01 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
M59979 | 88474 | PTGS1 | 1.394 | 0.00734 |
43 | 0006693 | prostaglandin metabolism | H006848_01 | Prostaglandin D2 synthase (21kD, brain) | NM_000954 | 8272 | PTGDS | 0.872 | 0.10275 |
44 | 0004867 | serine-type endopeptidase inhibitor activity | H001614_01 | Prostatic binding protein | X75252 | 80423 | PBP | 1.121 | 0.01436 |
45 | 0004867 | serine-type endopeptidase inhibitor activity | H001778_01 | Gastrointestinal peptide | AF048700 | 129778 | PEC-60 | 0.842 | 0.00941 |
46 | 0004867 | serine-type endopeptidase inhibitor activity | H001786_01 | Serine protease inhibitor, Kazal type, 2 (acrosin-trypsin inhibitor) |
X57655 | 98243 | SPINK2 | 0.956 | 0.58868 |
47 | 0004867 | serine-type endopeptidase inhibitor activity | H001803_01 | Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 8 |
L40377 | 41726 | SERPINB8 | 1.026 | 0.63053 |
48 | 0004867 | serine-type endopeptidase inhibitor activity | H001902_01 | Alpha-2-macroglobulin | M11313 | 74561 | A2M | 1.028 | 0.77516 |
49 | 0004867 | serine-type endopeptidase inhibitor activity | H001937_01 | Serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
X01683 | 297681 | SERPINA1 | 1.004 | 0.95043 |
50 | 0004867 | serine-type endopeptidase inhibitor activity | H001981_01 | Collagen, type VI, alpha 3 | X52022 | 80988 | COL6A3 | 1.173 | 0.0519 |
51 | 0004867 | serine-type endopeptidase inhibitor activity | H002016_01 | Amyloid beta (A4) precursor-like protein 2 | S60099 | 279518 | APLP2 | 0.856 | 0.01972 |
52 | 0004867 | serine-type endopeptidase inhibitor activity | H002067_01 | Pre-alpha (globulin) inhibitor, H3 polypeptide | X67055 | 76716 | ITIH3 | 0.925 | 0.23704 |
53 | 0004867 | serine-type endopeptidase inhibitor activity | H002283_01 | Secretory leukocyte protease inhibitor (antileukoproteinase) | X04470 | 251754 | SLPI | 0.907 | 0.1344 |
54 | 0004867 | serine-type endopeptidase inhibitor activity | H002553_01 | Serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), |
M14083 | 82085 | SERPINE1 | 1.045 | 0.39102 |
55 | 0004867 | serine-type endopeptidase inhibitor activity | H002655_01 | Collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) |
L02870 | 1640 | COL7A1 | 1.553 | p < 1e-07 |
56 | 0004867 | serine-type endopeptidase inhibitor activity | H002674_01 | Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 1 |
M93056 | 183583 | SERPINB1 | 0.914 | 0.23786 |
57 | 0004867 | serine-type endopeptidase inhibitor activity | H002866_01 | Tissue factor pathway inhibitor 2 | D29992 | 295944 | TFPI2 | 0.976 | 0.87235 |
58 | 0004867 | serine-type endopeptidase inhibitor activity | H002927_01 | Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 2 |
Y00630 | 75716 | SERPINB2 | 1.092 | 0.4661 |
59 | 0004867 | serine-type endopeptidase inhibitor activity | H003006_01 | Serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 8 |
K02215 | 3697 | SERPINA8 | 0.872 | 0.07808 |
60 | 0004867 | serine-type endopeptidase inhibitor activity | H003294_01 | Serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
NM_001756 | 1305 | SERPINA6 | 1.034 | 0.53555 |
61 | 0004867 | serine-type endopeptidase inhibitor activity | H003880_01 | Inter-alpha (globulin) inhibitor, H2 polypeptide | X07173 | 75285 | ITIH2 | 0.905 | 0.20987 |
62 | 0004867 | serine-type endopeptidase inhibitor activity | H000459_01 | Serine protease inhibitor, Kunitz type, 2 | AF027205 | 31439 | SPINT2 | 0.921 | 0.22427 |
63 | 0004867 | serine-type endopeptidase inhibitor activity | H011225_01 | Serine (or cysteine) proteinase inhibitor, clade I (neuroserpin), member 2 |
AB006423 | 158308 | SERPINI2 | 0.836 | 0.09596 |
64 | 0004867 | serine-type endopeptidase inhibitor activity | H012614_01 | Reversion-inducing-cysteine-rich protein with kazal motifs | D50406 | 29640 | RECK | 0.716 | 0.02912 |
65 | 0004867 | serine-type endopeptidase inhibitor activity | H001117_01 | Serine (or cysteine) proteinase inhibitor, clade H (heat shock protein 47), member 2 |
D83174 | 9930 | SERPINH2 | 0.945 | 0.55266 |
66 | 0004867 | serine-type endopeptidase inhibitor activity | H001133_01 | Epididymis-specific, whey-acidic protein type, four-disulfide core; putative ovarian carcinoma marker |
X63187 | 2719 | HE4 | 0.971 | 0.51353 |
67 | 0016477 | cell migration | H002710_01 | Interleukin 10 | M57627 | 193717 | IL10 | 1.067 | 0.18138 |
68 | 0016477 | cell migration | H002937_01 | Fibronectin 1 | X02761 | 287820 | FN1 | 1.038 | 0.4994 |
69 | 0016477 | cell migration | H002944_01 | Interleukin 8 | M17017 | 624 | IL8 | 1.499 | 0.02976 |
70 | 0016477 | cell migration | H003013_01 | Vascular endothelial growth factor C | U43142 | 79141 | VEGFC | 1.208 | 0.03351 |
71 | 0016477 | cell migration | H003139_01 | Integrin, beta 2 (antigen CD18 (p95), lymphocyte function-associated antigen 1; macrophage antigen 1 |
M15395 | 83968 | ITGB2 | 0.932 | 0.49748 |
72 | 0016477 | cell migration | H003298_01 | Laminin, alpha 4 | S78569 | 78672 | LAMA4 | 0.777 | 0.00645 |
73 | 0016477 | cell migration | H003652_01 | Apolipoprotein E | M12529 | 169401 | APOE | 1.005 | 0.94163 |
74 | 0016477 | cell migration | H003847_01 | Laminin, alpha 2 (merosin, congenital muscular dystrophy) | Z26653 | 75279 | LAMA2 | 0.924 | 0.33276 |
75 | 0016477 | cell migration | H000396_01 | Fasciculation and elongation protein zeta 1 (zygin I) | U60060 | 79226 | FEZ1 | 0.935 | 0.23095 |
76 | 0016477 | cell migration | H004459_01 | Spondin 2, extracellular matrix protein | NM_012445 | 288126 | SPON2 | 0.926 | 0.37302 |
77 | 0016477 | cell migration | H006255_01 | Syndecan binding protein (syntenin) | AF000652 | 8180 | SDCBP | 0.83 | 0.02079 |
78 | 0016477 | cell migration | H007856_01 | Chemokine-like factor, alternatively spliced | NM_016951 | 15159 | LOC51192 | 1.07 | 0.20793 |
79 | 0016477 | cell migration | H000663_01 | Plexin B1 | AB007867 | 278311 | PLXNB1 | 0.852 | 0.02089 |
80 | 0016477 | cell migration | H008817_01 | Prostate derived STE20-like kinase PSK | NM_016151 | 66141 | PSK | 1.045 | 0.47302 |
81 | 0016477 | cell migration | H009347_01 | Neuronal cell adhesion molecule | AB002341 | 7912 | NRCAM | 0.584 | 1e-05 |
82 | 0016477 | cell migration | H010897_01 | DKFZP434H168 protein | AL117580 | 241431 | DKFZP434H168 | 0.862 | 0.01431 |
83 | 0016477 | cell migration | H010900_01 | Homo sapiens mRNA for plexin-B1 plasma membrane receptor, truncated splice variant (plexin-B1/SEP ge |
AJ011414 | 312939 | 0.953 | 0.49831 | |
84 | 0016477 | cell migration | H011466_01 | Thousand and one amino acid protein kinase | AB020688 | 122823 | TAO1 | 0.99 | 0.82505 |
85 | 0016477 | cell migration | H012243_01 | Dedicator of cyto-kinesis 2 | D86964 | 17211 | DOCK2 | 1.086 | 0.11723 |
86 | 0016477 | cell migration | H000901_01 | Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
U28369 | 82222 | SEMA3B | 0.921 | 0.24356 |
87 | 0016477 | cell migration | H013086_01 | Oligophrenin 1 | AJ001189 | 128824 | OPHN1 | 1.059 | 0.43883 |
88 | 0016477 | cell migration | H015948_01 | Homo sapiens cDNA: FLJ22401 fis, clone HRC08032, highly similar to AB027466 Homo sapiens SPON2 mRNA |
AK024499 | 306919 | 0.785 | 0.01505 | |
89 | 0016477 | cell migration | H016066_01 | Homo sapiens mRNA for MSF-FN70 (FN gene) | AJ276395 | 321592 | 1.086 | 0.4075 | |
90 | 0016477 | cell migration | H016249_01 | Homo sapiens, Similar to laminin, alpha 4, clone MGC:10389, mRNA, complete cds |
BC004241 | 327703 | 1.047 | 0.43404 | |
91 | 0016477 | cell migration | H001178_01 | Pregnancy specific beta-1-glycoprotein 11 | M20882 | 321450 | PSG11 | 0.862 | 0.07474 |
92 | 0016477 | cell migration | H001239_01 | Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (se |
AB021292 | 25887 | SEMA4F | 0.972 | 0.6257 |
93 | 0030934 | anchoring collagen | H001981_01 | Collagen, type VI, alpha 3 | X52022 | 80988 | COL6A3 | 1.173 | 0.0519 |
94 | 0030934 | anchoring collagen | H002090_01 | Collagen, type XVI, alpha 1 | M92642 | 26208 | COL16A1 | 0.927 | 0.27606 |
95 | 0030934 | anchoring collagen | H002655_01 | Collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) |
L02870 | 1640 | COL7A1 | 1.553 | p < 1e-07 |
96 | 0030934 | anchoring collagen | H000717_01 | Collagen, type IX, alpha 3 | L41162 | 53563 | COL9A3 | 1.05 | 0.45955 |
97 | 0030934 | anchoring collagen | H000734_01 | Collagen, type XIV, alpha 1 (undulin) | Y11710 | 36131 | COL14A1 | 1.002 | 0.98122 |
98 | 0030934 | anchoring collagen | H000774_01 | Collagen, type VI, alpha 1 | X15880 | 108885 | COL6A1 | 1.005 | 0.94306 |
99 | 0005201 | extracellular matrix structural constituent | H001909_01 | Collagen, type IV, alpha 2 | X05610 | 75617 | COL4A2 | 1.108 | 0.39407 |
100 | 0005201 | extracellular matrix structural constituent | H001981_01 | Collagen, type VI, alpha 3 | X52022 | 80988 | COL6A3 | 1.173 | 0.0519 |
101 | 0005201 | extracellular matrix structural constituent | H002090_01 | Collagen, type XVI, alpha 1 | M92642 | 26208 | COL16A1 | 0.927 | 0.27606 |
102 | 0005201 | extracellular matrix structural constituent | H002143_01 | Fibrillin 1 (Marfan syndrome) | X63556 | 750 | FBN1 | 0.849 | 0.01231 |
103 | 0005201 | extracellular matrix structural constituent | H002160_01 | Collagen, type V, alpha 2 | Y14690 | 82985 | COL5A2 | 0.867 | 0.10761 |
104 | 0005201 | extracellular matrix structural constituent | H002196_01 | Nidogen (enactin) | M30269 | 62041 | NID | 0.915 | 0.21702 |
105 | 0005201 | extracellular matrix structural constituent | H002207_01 | Fibrillin 2 (congenital contractural arachnodactyly) | U03272 | 79432 | FBN2 | 1.137 | 0.50187 |
106 | 0005201 | extracellular matrix structural constituent | H002306_01 | Collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) |
X14420 | 119571 | COL3A1 | 0.907 | 0.39389 |
107 | 0005201 | extracellular matrix structural constituent | H002647_01 | Collagen, type XV, alpha 1 | L25286 | 83164 | COL15A1 | 1.005 | 0.91556 |
108 | 0005201 | extracellular matrix structural constituent | H002655_01 | Collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) |
L02870 | 1640 | COL7A1 | 1.553 | p < 1e-07 |
109 | 0005201 | extracellular matrix structural constituent | H002759_01 | Collagen, type IV, alpha 6 | D21337 | 408 | COL4A6 | 1.025 | 0.70581 |
110 | 0005201 | extracellular matrix structural constituent | H002866_01 | Tissue factor pathway inhibitor 2 | D29992 | 295944 | TFPI2 | 0.976 | 0.87235 |
111 | 0005201 | extracellular matrix structural constituent | H002915_01 | Collagen, type VIII, alpha 1 | X57527 | 114599 | COL8A1 | 1.092 | 0.38509 |
112 | 0005201 | extracellular matrix structural constituent | H002937_01 | Fibronectin 1 | X02761 | 287820 | FN1 | 1.038 | 0.4994 |
113 | 0005201 | extracellular matrix structural constituent | H002994_01 | Collagen, type XVIII, alpha 1 | AF018081 | 78409 | COL18A1 | 1.757 | 8e-05 |
114 | 0005201 | extracellular matrix structural constituent | H003072_01 | Collagen, type I, alpha 2 | J03464 | 179573 | COL1A2 | 0.954 | 0.62985 |
115 | 0005201 | extracellular matrix structural constituent | H003298_01 | Laminin, alpha 4 | S78569 | 78672 | LAMA4 | 0.777 | 0.00645 |
116 | 0005201 | extracellular matrix structural constituent | H003413_01 | Lumican | U21128 | 79914 | LUM | 0.854 | 0.1425 |
117 | 0005201 | extracellular matrix structural constituent | H003593_01 | Collagen, type VI, alpha 2 | AL096746 | 159263 | COL6A2 | 0.991 | 0.87376 |
118 | 0005201 | extracellular matrix structural constituent | H004095_01 | Collagen, type V, alpha 3 | AF177941 | 235368 | COL5A3 | 1.07 | 0.41285 |
119 | 0005201 | extracellular matrix structural constituent | H004275_01 | Elastin microfibril interface located protein | AL050138 | 63348 | EMILIN | 0.965 | 0.50466 |
120 | 0005201 | extracellular matrix structural constituent | H005324_01 | Elastin microfibril interface located protein | NM_007046 | 63348 | EMILIN | 0.907 | 0.20922 |
121 | 0005201 | extracellular matrix structural constituent | H005515_01 | EGF-containing fibulin-like extracellular matrix protein 2 | AJ132819 | 6059 | EFEMP2 | 0.982 | 0.79014 |
122 | 0005201 | extracellular matrix structural constituent | H006623_01 | Homo sapiens clone HB-2 mRNA sequence | AF216077 | 48376 | 1.142 | 0.17143 | |
123 | 0005201 | extracellular matrix structural constituent | H000717_01 | Collagen, type IX, alpha 3 | L41162 | 53563 | COL9A3 | 1.05 | 0.45955 |
124 | 0005201 | extracellular matrix structural constituent | H000734_01 | Collagen, type XIV, alpha 1 (undulin) | Y11710 | 36131 | COL14A1 | 1.002 | 0.98122 |
125 | 0005201 | extracellular matrix structural constituent | H000774_01 | Collagen, type VI, alpha 1 | X15880 | 108885 | COL6A1 | 1.005 | 0.94306 |
126 | 0005201 | extracellular matrix structural constituent | H011443_01 | EGF-containing fibulin-like extracellular matrix protein 2 | AF109121 | 6059 | EFEMP2 | 1.132 | 0.12457 |
127 | 0005201 | extracellular matrix structural constituent | H011464_01 | Microfibrillar-associated protein 3 | AL049404 | 28785 | MFAP3 | 1.034 | 0.57907 |
128 | 0005201 | extracellular matrix structural constituent | H012686_01 | Collagen, type XIII, alpha 1 | NM_005203 | 211933 | COL13A1 | 1.064 | 0.5062 |
129 | 0005201 | extracellular matrix structural constituent | H000992_01 | Fibulin 2 | X82494 | 198862 | FBLN2 | 1.019 | 0.79659 |
130 | 0005201 | extracellular matrix structural constituent | H014507_01 | P3ECSL | NM_022164 | 173508 | LIECG3 | 0.934 | 0.25276 |
131 | 0005201 | extracellular matrix structural constituent | H001006_01 | Microfibrillar-associated protein 3 | AK000358 | 28785 | MFAP3 | 0.934 | 0.32753 |
132 | 0005201 | extracellular matrix structural constituent | H015060_01 | Smooth muscle cell-expressed and macrophage conditioned medium-induced protein smag-64 |
NM_020351 | 283100 | LOC57086 | 1.121 | 0.13171 |
133 | 0005201 | extracellular matrix structural constituent | H016066_01 | Homo sapiens mRNA for MSF-FN70 (FN gene) | AJ276395 | 321592 | 1.086 | 0.4075 | |
134 | 0005201 | extracellular matrix structural constituent | H016249_01 | Homo sapiens, Similar to laminin, alpha 4, clone MGC:10389, mRNA, complete cds |
BC004241 | 327703 | 1.047 | 0.43404 | |
135 | 0005201 | extracellular matrix structural constituent | H001143_01 | Matrilin 1, cartilage matrix protein | M55683 | 150366 | MATN1 | 1.128 | 0.03901 |
136 | 0005201 | extracellular matrix structural constituent | H001149_01 | Microfibrillar-associated protein 2 | U19718 | 83551 | MFAP2 | 0.842 | 0.0108 |
137 | 0005201 | extracellular matrix structural constituent | H001163_01 | Cartilage linking protein 1 | U43328 | 2799 | CRTL1 | 0.649 | 0.0585 |
138 | 0005201 | extracellular matrix structural constituent | H001200_01 | Microfibril-associated glycoprotein-2 | NM_003480 | 300946 | MAGP2 | 0.792 | 0.02533 |
139 | 0006956 | complement activation | H002203_01 | Complement component 4-binding protein, alpha | M31452 | 1012 | C4BPA | 0.981 | 0.7132 |
140 | 0006956 | complement activation | H002407_01 | I factor (complement) | Y00318 | 36602 | IF | 0.87 | 0.08583 |
141 | 0006956 | complement activation | H002469_01 | Complement component 3 | K02765 | 284394 | C3 | 1.036 | 0.66839 |
142 | 0006956 | complement activation | H002497_01 | Complement component 1, r subcomponent | M14058 | 1279 | C1R | 0.684 | 0.00136 |
143 | 0006956 | complement activation | H002509_01 | D component of complement (adipsin) | M84526 | 155597 | DF | 1.01 | 0.8622 |
144 | 0006956 | complement activation | H002515_01 | Clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed pro |
M25915 | 75106 | CLU | 0.91 | 0.46421 |
145 | 0006956 | complement activation | H002605_01 | Mannan-binding lectin serine protease 2 | X98400 | 119983 | MASP2 | 1.039 | 0.55015 |
146 | 0006956 | complement activation | H002805_01 | Membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen) |
X59405 | 83532 | MCP | 0.784 | 0.0075 |
147 | 0006956 | complement activation | H002996_01 | Complement component (3d/Epstein Barr virus) receptor 2 | J03565 | 73792 | CR2 | 0.978 | 0.81221 |
148 | 0006956 | complement activation | H003011_01 | Complement component 1, s subcomponent | J04080 | 169756 | C1S | 0.811 | 0.02135 |
149 | 0006956 | complement activation | H003337_01 | B-factor, properdin | L15702 | 69771 | BF | 0.972 | 0.75801 |
150 | 0006956 | complement activation | H003528_01 | Decay accelerating factor for complement (CD55, Cromer blood group system) |
M30142 | 1369 | DAF | 0.621 | 0 |
151 | 0006956 | complement activation | H011506_01 | Homo sapiens mRNA; cDNA DKFZp586F0824 (from clone DKFZp586F0824); partial cds |
AL137646 | 146001 | 0.794 | 0.05535 | |
152 | 0006956 | complement activation | H001027_01 | Complement component 8, alpha polypeptide | M16974 | 93210 | C8A | 0.954 | 0.48929 |
153 | 0006956 | complement activation | H001061_01 | Complement component 4A | K02403 | 170250 | C4A | 1.04 | 0.62746 |
154 | 0006956 | complement activation | H015664_01 | Human MHC class III serum complement factor B, mRNA | K01566 | 294163 | 1.018 | 0.82251 | |
155 | 0046519 | sphingoid metabolism | H000025_01 | Neutral sphingomyelinase (N-SMase) activation associated factor |
X96586 | 78687 | NSMAF | 0.742 | 0.00058 |
156 | 0046519 | sphingoid metabolism | H004193_01 | Sialyltransferase 9 (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase; GM3 synthase) |
AB018356 | 225939 | SIAT9 | 0.814 | 0.06525 |
157 | 0046519 | sphingoid metabolism | H000464_01 | Protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform |
M65254 | 108705 | PPP2R1B | 0.937 | 0.24318 |
158 | 0046519 | sphingoid metabolism | H008553_01 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | AB022017 | 9247 | PRKAA1 | 1.089 | 0.15692 |
159 | 0046519 | sphingoid metabolism | H000076_01 | UDP-glucose ceramide glucosyltransferase | D50840 | 152601 | UGCG | 0.81 | 0.01527 |
160 | 0046519 | sphingoid metabolism | H001062_01 | N-acylsphingosine amidohydrolase (acid ceramidase) | U70063 | 75811 | ASAH | 0.761 | 0.00155 |
161 | 0046519 | sphingoid metabolism | H015734_01 | Sphingosine kinase type 2 isoform | AL136701 | 301305 | SPHK2 | 1.009 | 0.87246 |
162 | 0046519 | sphingoid metabolism | H016485_01 | Sphingosine kinase 1 | NM_021972 | 68061 | SPHK1 | 1.013 | 0.883 |
163 | 0046519 | sphingoid metabolism | H001148_01 | Galactosylceramidase (Krabbe disease) | NM_000153 | 273 | GALC | 0.883 | 0.0751 |
164 | 0000323 | lytic vacuole | H001771_01 | Cathepsin S | M90696 | 181301 | CTSS | 1.092 | 0.12339 |
165 | 0000323 | lytic vacuole | H001912_01 | Hyaluronoglucosaminidase 1 | U03056 | 75619 | HYAL1 | 0.963 | 0.64564 |
166 | 0000323 | lytic vacuole | H001982_01 | Deoxyribonuclease II, lysosomal | AF060222 | 118243 | DNASE2 | 0.851 | 0.00663 |
167 | 0000323 | lytic vacuole | H002064_01 | Galactosidase, beta 1 | M34423 | 79222 | GLB1 | 0.816 | 0.01277 |
168 | 0000323 | lytic vacuole | H002077_01 | Glucosamine (N-acetyl)-6-sulfatase (Sanfilippo disease IIID) | Z12173 | 321070 | GNS | 0.93 | 0.26928 |
169 | 0000323 | lytic vacuole | H002157_01 | Prolylcarboxypeptidase (angiotensinase C) | L13977 | 75693 | PRCP | 0.815 | 0.00463 |
170 | 0000323 | lytic vacuole | H002162_01 | Lysosomal-associated membrane protein 2 | U36336 | 8262 | LAMP2 | 0.864 | 0.01474 |
171 | 0000323 | lytic vacuole | H002185_01 | Niemann-Pick disease, type C1 | AF002020 | 76918 | NPC1 | 0.803 | 0.00028 |
172 | 0000323 | lytic vacuole | H002206_01 | Protease, cysteine, 1 (legumain) | D55696 | 18069 | PRSC1 | 1.008 | 0.90457 |
173 | 0000323 | lytic vacuole | H002235_01 | Ubiquitin specific protease 6 (Tre-2 oncogene) | X63547 | 111065 | USP6 | 0.954 | 0.41203 |
174 | 0000323 | lytic vacuole | H002290_01 | Acid phosphatase 5, tartrate resistant | NM_001611 | 1211 | ACP5 | 1.087 | 0.31928 |
175 | 0000323 | lytic vacuole | H002483_01 | Lysosomal-associated membrane protein 1 | J04182 | 150101 | LAMP1 | 0.925 | 0.0685 |
176 | 0000323 | lytic vacuole | H002697_01 | Myeloperoxidase | M19507 | 1817 | MPO | 1.015 | 0.85413 |
177 | 0000323 | lytic vacuole | H002897_01 | Cathepsin L | X12451 | 78056 | CTSL | 0.808 | 0.00407 |
178 | 0000323 | lytic vacuole | H002948_01 | Ubiquitin specific protease 4 (proto-oncogene) | U20657 | 77500 | USP4 | 1.105 | 0.14385 |
179 | 0000323 | lytic vacuole | H003016_01 | Insulin-like growth factor 2 receptor | Y00285 | 76473 | IGF2R | 0.825 | 0.00995 |
180 | 0000323 | lytic vacuole | H003024_01 | Cathepsin H | X16832 | 288181 | CTSH | 0.804 | 0.02033 |
181 | 0000323 | lytic vacuole | H003138_01 | Gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
U55206 | 78619 | GGH | 1.034 | 0.64814 |
182 | 0000323 | lytic vacuole | H003235_01 | GM2 ganglioside activator protein | X62078 | 69743 | GM2A | 0.957 | 0.41765 |
183 | 0000323 | lytic vacuole | H003254_01 | Cathepsin C | X87212 | 10029 | CTSC | 0.996 | 0.97068 |
184 | 0000323 | lytic vacuole | H003300_01 | CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane |
D12676 | 323567 | CD36L2 | 1.055 | 0.33252 |
185 | 0000323 | lytic vacuole | H003466_01 | CD68 antigen | S57235 | 246381 | CD68 | 0.988 | 0.7745 |
186 | 0000323 | lytic vacuole | H003574_01 | TIA1 cytotoxic granule-associated RNA-binding protein-like 1 | D64015 | 182741 | TIAL1 | 1.011 | 0.83837 |
187 | 0000323 | lytic vacuole | H003805_01 | Lipase A, lysosomal acid, cholesterol esterase (Wolman disease) |
X76488 | 85226 | LIPA | 0.896 | 0.24882 |
188 | 0000323 | lytic vacuole | H003836_01 | Glucuronidase, beta | M15182 | 183868 | GUSB | 0.974 | 0.68456 |
189 | 0000323 | lytic vacuole | H005593_01 | Homo sapiens clone 23645 mRNA sequence | AF052100 | 6651 | 0.956 | 0.57587 | |
190 | 0000323 | lytic vacuole | H006334_01 | LCAT-like lysophospholipase | AL110209 | 6770 | LLPL | 0.897 | 0.14363 |
191 | 0000323 | lytic vacuole | H006538_01 | Ceroid-lipofuscinosis, neuronal 5 | AF068227 | 30213 | CLN5 | 0.933 | 0.28364 |
192 | 0000323 | lytic vacuole | H007373_01 | Prenylcysteine lyase | AB020715 | 278627 | PCL1 | 1.03 | 0.62083 |
193 | 0000323 | lytic vacuole | H007535_01 | Hyaluronoglucosaminidase 2 | U09577 | 76873 | HYAL2 | 0.961 | 0.37587 |
194 | 0000323 | lytic vacuole | H000633_01 | Coronin, actin-binding protein, 1A | D44497 | 109606 | CORO1A | 0.945 | 0.24739 |
195 | 0000323 | lytic vacuole | H008567_01 | Sialidase 1 (lysosomal sialidase) | AF040958 | 118721 | NEU1 | 0.833 | 0.01207 |
196 | 0000323 | lytic vacuole | H009939_01 | Hypothetical protein | AF151020 | 181444 | LOC51235 | 1.017 | 0.74195 |
197 | 0000323 | lytic vacuole | H000751_01 | Anti-oxidant protein 2 (non-selenium glutathione peroxidase, acidic calcium-independent phospholipas |
D14662 | 120 | KIAA0106 | 1.121 | 0.08672 |
198 | 0000323 | lytic vacuole | H010783_01 | Palmitoyl-protein thioesterase 2 | AF020544 | 81737 | PPT2 | 0.999 | 0.99101 |
199 | 0000323 | lytic vacuole | H000868_01 | Mannosidase, beta A, lysosomal | U60337 | 115945 | MANBA | 0.922 | 0.19365 |
200 | 0000323 | lytic vacuole | H000877_01 | Sphingomyelin phosphodiesterase 1, acid lysosomal (acid sphingomyelinase) |
X59960 | 77813 | SMPD1 | 0.93 | 0.19544 |
201 | 0000323 | lytic vacuole | H000879_01 | Chitobiase, di-N-acetyl- | M95767 | 135578 | CTBS | 0.907 | 0.15643 |
202 | 0000323 | lytic vacuole | H012397_01 | ESTs | X78261 | 272177 | 1.028 | 0.65963 | |
203 | 0000323 | lytic vacuole | H000887_01 | Prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy) |
J03077 | 78575 | PSAP | 0.85 | 0.03087 |
204 | 0000323 | lytic vacuole | H012727_01 | Cathepsin F | NM_003793 | 11590 | CTSF | 0.993 | 0.93097 |
205 | 0000323 | lytic vacuole | H000926_01 | Transmembrane 4 superfamily member 3 | M35252 | 84072 | TM4SF3 | 1.04 | 0.49676 |
206 | 0000323 | lytic vacuole | H000932_01 | N-sulfoglucosamine sulfohydrolase (sulfamidase) | U30894 | 31074 | SGSH | 0.929 | 0.35523 |
207 | 0000323 | lytic vacuole | H014980_01 | Glucosidase, beta; acid (includes glucosylceramidase) | NM_000157 | 282997 | GBA | 0.882 | 0.09493 |
208 | 0000323 | lytic vacuole | H001062_01 | N-acylsphingosine amidohydrolase (acid ceramidase) | U70063 | 75811 | ASAH | 0.761 | 0.00155 |
209 | 0000323 | lytic vacuole | H001066_01 | Fucosidase, alpha-L- 1, tissue | M29877 | 576 | FUCA1 | 0.914 | 0.19066 |
210 | 0000323 | lytic vacuole | H015633_01 | GM2 ganglioside activator protein | NM_000405 | 289082 | GM2A | 1.007 | 0.91285 |
211 | 0000323 | lytic vacuole | H015696_01 | Cathepsin B | NM_001908 | 297939 | CTSB | 0.918 | 0.30063 |
212 | 0000323 | lytic vacuole | H001083_01 | Low density lipoprotein-related protein 2 | U33837 | 153595 | LRP2 | 0.925 | 0.20154 |
213 | 0000323 | lytic vacuole | H001085_01 | Mannosidase, alpha, class 2B, member 1 | U68382 | 279854 | MAN2B1 | 1.039 | 0.56235 |
214 | 0000323 | lytic vacuole | H001116_01 | Steroid sulfatase (microsomal), arylsulfatase C, isozyme S | M16505 | 79876 | STS | 0.812 | 0.00508 |
215 | 0000323 | lytic vacuole | H001148_01 | Galactosylceramidase (Krabbe disease) | NM_000153 | 273 | GALC | 0.883 | 0.0751 |
216 | 0000323 | lytic vacuole | H001177_01 | Palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile) |
U44772 | 3873 | PPT1 | 0.987 | 0.84861 |
217 | 0000323 | lytic vacuole | H001185_01 | Arylsulfatase A | NM_000487 | 88251 | ARSA | 0.904 | 0.14918 |
218 | 0005764 | lysosome | H001771_01 | Cathepsin S | M90696 | 181301 | CTSS | 1.092 | 0.12339 |
219 | 0005764 | lysosome | H001912_01 | Hyaluronoglucosaminidase 1 | U03056 | 75619 | HYAL1 | 0.963 | 0.64564 |
220 | 0005764 | lysosome | H001982_01 | Deoxyribonuclease II, lysosomal | AF060222 | 118243 | DNASE2 | 0.851 | 0.00663 |
221 | 0005764 | lysosome | H002064_01 | Galactosidase, beta 1 | M34423 | 79222 | GLB1 | 0.816 | 0.01277 |
222 | 0005764 | lysosome | H002077_01 | Glucosamine (N-acetyl)-6-sulfatase (Sanfilippo disease IIID) | Z12173 | 321070 | GNS | 0.93 | 0.26928 |
223 | 0005764 | lysosome | H002157_01 | Prolylcarboxypeptidase (angiotensinase C) | L13977 | 75693 | PRCP | 0.815 | 0.00463 |
224 | 0005764 | lysosome | H002162_01 | Lysosomal-associated membrane protein 2 | U36336 | 8262 | LAMP2 | 0.864 | 0.01474 |
225 | 0005764 | lysosome | H002185_01 | Niemann-Pick disease, type C1 | AF002020 | 76918 | NPC1 | 0.803 | 0.00028 |
226 | 0005764 | lysosome | H002206_01 | Protease, cysteine, 1 (legumain) | D55696 | 18069 | PRSC1 | 1.008 | 0.90457 |
227 | 0005764 | lysosome | H002235_01 | Ubiquitin specific protease 6 (Tre-2 oncogene) | X63547 | 111065 | USP6 | 0.954 | 0.41203 |
228 | 0005764 | lysosome | H002290_01 | Acid phosphatase 5, tartrate resistant | NM_001611 | 1211 | ACP5 | 1.087 | 0.31928 |
229 | 0005764 | lysosome | H002483_01 | Lysosomal-associated membrane protein 1 | J04182 | 150101 | LAMP1 | 0.925 | 0.0685 |
230 | 0005764 | lysosome | H002697_01 | Myeloperoxidase | M19507 | 1817 | MPO | 1.015 | 0.85413 |
231 | 0005764 | lysosome | H002897_01 | Cathepsin L | X12451 | 78056 | CTSL | 0.808 | 0.00407 |
232 | 0005764 | lysosome | H002948_01 | Ubiquitin specific protease 4 (proto-oncogene) | U20657 | 77500 | USP4 | 1.105 | 0.14385 |
233 | 0005764 | lysosome | H003016_01 | Insulin-like growth factor 2 receptor | Y00285 | 76473 | IGF2R | 0.825 | 0.00995 |
234 | 0005764 | lysosome | H003024_01 | Cathepsin H | X16832 | 288181 | CTSH | 0.804 | 0.02033 |
235 | 0005764 | lysosome | H003138_01 | Gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
U55206 | 78619 | GGH | 1.034 | 0.64814 |
236 | 0005764 | lysosome | H003235_01 | GM2 ganglioside activator protein | X62078 | 69743 | GM2A | 0.957 | 0.41765 |
237 | 0005764 | lysosome | H003254_01 | Cathepsin C | X87212 | 10029 | CTSC | 0.996 | 0.97068 |
238 | 0005764 | lysosome | H003300_01 | CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane |
D12676 | 323567 | CD36L2 | 1.055 | 0.33252 |
239 | 0005764 | lysosome | H003466_01 | CD68 antigen | S57235 | 246381 | CD68 | 0.988 | 0.7745 |
240 | 0005764 | lysosome | H003574_01 | TIA1 cytotoxic granule-associated RNA-binding protein-like 1 | D64015 | 182741 | TIAL1 | 1.011 | 0.83837 |
241 | 0005764 | lysosome | H003805_01 | Lipase A, lysosomal acid, cholesterol esterase (Wolman disease) |
X76488 | 85226 | LIPA | 0.896 | 0.24882 |
242 | 0005764 | lysosome | H003836_01 | Glucuronidase, beta | M15182 | 183868 | GUSB | 0.974 | 0.68456 |
243 | 0005764 | lysosome | H005593_01 | Homo sapiens clone 23645 mRNA sequence | AF052100 | 6651 | 0.956 | 0.57587 | |
244 | 0005764 | lysosome | H006334_01 | LCAT-like lysophospholipase | AL110209 | 6770 | LLPL | 0.897 | 0.14363 |
245 | 0005764 | lysosome | H006538_01 | Ceroid-lipofuscinosis, neuronal 5 | AF068227 | 30213 | CLN5 | 0.933 | 0.28364 |
246 | 0005764 | lysosome | H007373_01 | Prenylcysteine lyase | AB020715 | 278627 | PCL1 | 1.03 | 0.62083 |
247 | 0005764 | lysosome | H007535_01 | Hyaluronoglucosaminidase 2 | U09577 | 76873 | HYAL2 | 0.961 | 0.37587 |
248 | 0005764 | lysosome | H000633_01 | Coronin, actin-binding protein, 1A | D44497 | 109606 | CORO1A | 0.945 | 0.24739 |
249 | 0005764 | lysosome | H008567_01 | Sialidase 1 (lysosomal sialidase) | AF040958 | 118721 | NEU1 | 0.833 | 0.01207 |
250 | 0005764 | lysosome | H009939_01 | Hypothetical protein | AF151020 | 181444 | LOC51235 | 1.017 | 0.74195 |
251 | 0005764 | lysosome | H000751_01 | Anti-oxidant protein 2 (non-selenium glutathione peroxidase, acidic calcium-independent phospholipas |
D14662 | 120 | KIAA0106 | 1.121 | 0.08672 |
252 | 0005764 | lysosome | H010783_01 | Palmitoyl-protein thioesterase 2 | AF020544 | 81737 | PPT2 | 0.999 | 0.99101 |
253 | 0005764 | lysosome | H000868_01 | Mannosidase, beta A, lysosomal | U60337 | 115945 | MANBA | 0.922 | 0.19365 |
254 | 0005764 | lysosome | H000877_01 | Sphingomyelin phosphodiesterase 1, acid lysosomal (acid sphingomyelinase) |
X59960 | 77813 | SMPD1 | 0.93 | 0.19544 |
255 | 0005764 | lysosome | H000879_01 | Chitobiase, di-N-acetyl- | M95767 | 135578 | CTBS | 0.907 | 0.15643 |
256 | 0005764 | lysosome | H012397_01 | ESTs | X78261 | 272177 | 1.028 | 0.65963 | |
257 | 0005764 | lysosome | H000887_01 | Prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy) |
J03077 | 78575 | PSAP | 0.85 | 0.03087 |
258 | 0005764 | lysosome | H012727_01 | Cathepsin F | NM_003793 | 11590 | CTSF | 0.993 | 0.93097 |
259 | 0005764 | lysosome | H000926_01 | Transmembrane 4 superfamily member 3 | M35252 | 84072 | TM4SF3 | 1.04 | 0.49676 |
260 | 0005764 | lysosome | H000932_01 | N-sulfoglucosamine sulfohydrolase (sulfamidase) | U30894 | 31074 | SGSH | 0.929 | 0.35523 |
261 | 0005764 | lysosome | H014980_01 | Glucosidase, beta; acid (includes glucosylceramidase) | NM_000157 | 282997 | GBA | 0.882 | 0.09493 |
262 | 0005764 | lysosome | H001062_01 | N-acylsphingosine amidohydrolase (acid ceramidase) | U70063 | 75811 | ASAH | 0.761 | 0.00155 |
263 | 0005764 | lysosome | H001066_01 | Fucosidase, alpha-L- 1, tissue | M29877 | 576 | FUCA1 | 0.914 | 0.19066 |
264 | 0005764 | lysosome | H015633_01 | GM2 ganglioside activator protein | NM_000405 | 289082 | GM2A | 1.007 | 0.91285 |
265 | 0005764 | lysosome | H015696_01 | Cathepsin B | NM_001908 | 297939 | CTSB | 0.918 | 0.30063 |
266 | 0005764 | lysosome | H001083_01 | Low density lipoprotein-related protein 2 | U33837 | 153595 | LRP2 | 0.925 | 0.20154 |
267 | 0005764 | lysosome | H001085_01 | Mannosidase, alpha, class 2B, member 1 | U68382 | 279854 | MAN2B1 | 1.039 | 0.56235 |
268 | 0005764 | lysosome | H001116_01 | Steroid sulfatase (microsomal), arylsulfatase C, isozyme S | M16505 | 79876 | STS | 0.812 | 0.00508 |
269 | 0005764 | lysosome | H001148_01 | Galactosylceramidase (Krabbe disease) | NM_000153 | 273 | GALC | 0.883 | 0.0751 |
270 | 0005764 | lysosome | H001177_01 | Palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile) |
U44772 | 3873 | PPT1 | 0.987 | 0.84861 |
271 | 0005764 | lysosome | H001185_01 | Arylsulfatase A | NM_000487 | 88251 | ARSA | 0.904 | 0.14918 |
272 | 0005773 | vacuole | H001771_01 | Cathepsin S | M90696 | 181301 | CTSS | 1.092 | 0.12339 |
273 | 0005773 | vacuole | H001912_01 | Hyaluronoglucosaminidase 1 | U03056 | 75619 | HYAL1 | 0.963 | 0.64564 |
274 | 0005773 | vacuole | H001982_01 | Deoxyribonuclease II, lysosomal | AF060222 | 118243 | DNASE2 | 0.851 | 0.00663 |
275 | 0005773 | vacuole | H002064_01 | Galactosidase, beta 1 | M34423 | 79222 | GLB1 | 0.816 | 0.01277 |
276 | 0005773 | vacuole | H002077_01 | Glucosamine (N-acetyl)-6-sulfatase (Sanfilippo disease IIID) | Z12173 | 321070 | GNS | 0.93 | 0.26928 |
277 | 0005773 | vacuole | H002157_01 | Prolylcarboxypeptidase (angiotensinase C) | L13977 | 75693 | PRCP | 0.815 | 0.00463 |
278 | 0005773 | vacuole | H002162_01 | Lysosomal-associated membrane protein 2 | U36336 | 8262 | LAMP2 | 0.864 | 0.01474 |
279 | 0005773 | vacuole | H002185_01 | Niemann-Pick disease, type C1 | AF002020 | 76918 | NPC1 | 0.803 | 0.00028 |
280 | 0005773 | vacuole | H002206_01 | Protease, cysteine, 1 (legumain) | D55696 | 18069 | PRSC1 | 1.008 | 0.90457 |
281 | 0005773 | vacuole | H002235_01 | Ubiquitin specific protease 6 (Tre-2 oncogene) | X63547 | 111065 | USP6 | 0.954 | 0.41203 |
282 | 0005773 | vacuole | H002290_01 | Acid phosphatase 5, tartrate resistant | NM_001611 | 1211 | ACP5 | 1.087 | 0.31928 |
283 | 0005773 | vacuole | H002483_01 | Lysosomal-associated membrane protein 1 | J04182 | 150101 | LAMP1 | 0.925 | 0.0685 |
284 | 0005773 | vacuole | H002697_01 | Myeloperoxidase | M19507 | 1817 | MPO | 1.015 | 0.85413 |
285 | 0005773 | vacuole | H002897_01 | Cathepsin L | X12451 | 78056 | CTSL | 0.808 | 0.00407 |
286 | 0005773 | vacuole | H002948_01 | Ubiquitin specific protease 4 (proto-oncogene) | U20657 | 77500 | USP4 | 1.105 | 0.14385 |
287 | 0005773 | vacuole | H003016_01 | Insulin-like growth factor 2 receptor | Y00285 | 76473 | IGF2R | 0.825 | 0.00995 |
288 | 0005773 | vacuole | H003024_01 | Cathepsin H | X16832 | 288181 | CTSH | 0.804 | 0.02033 |
289 | 0005773 | vacuole | H003138_01 | Gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
U55206 | 78619 | GGH | 1.034 | 0.64814 |
290 | 0005773 | vacuole | H003235_01 | GM2 ganglioside activator protein | X62078 | 69743 | GM2A | 0.957 | 0.41765 |
291 | 0005773 | vacuole | H003254_01 | Cathepsin C | X87212 | 10029 | CTSC | 0.996 | 0.97068 |
292 | 0005773 | vacuole | H003300_01 | CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane |
D12676 | 323567 | CD36L2 | 1.055 | 0.33252 |
293 | 0005773 | vacuole | H003466_01 | CD68 antigen | S57235 | 246381 | CD68 | 0.988 | 0.7745 |
294 | 0005773 | vacuole | H003574_01 | TIA1 cytotoxic granule-associated RNA-binding protein-like 1 | D64015 | 182741 | TIAL1 | 1.011 | 0.83837 |
295 | 0005773 | vacuole | H003805_01 | Lipase A, lysosomal acid, cholesterol esterase (Wolman disease) |
X76488 | 85226 | LIPA | 0.896 | 0.24882 |
296 | 0005773 | vacuole | H003836_01 | Glucuronidase, beta | M15182 | 183868 | GUSB | 0.974 | 0.68456 |
297 | 0005773 | vacuole | H005593_01 | Homo sapiens clone 23645 mRNA sequence | AF052100 | 6651 | 0.956 | 0.57587 | |
298 | 0005773 | vacuole | H006334_01 | LCAT-like lysophospholipase | AL110209 | 6770 | LLPL | 0.897 | 0.14363 |
299 | 0005773 | vacuole | H006538_01 | Ceroid-lipofuscinosis, neuronal 5 | AF068227 | 30213 | CLN5 | 0.933 | 0.28364 |
300 | 0005773 | vacuole | H007373_01 | Prenylcysteine lyase | AB020715 | 278627 | PCL1 | 1.03 | 0.62083 |
301 | 0005773 | vacuole | H007535_01 | Hyaluronoglucosaminidase 2 | U09577 | 76873 | HYAL2 | 0.961 | 0.37587 |
302 | 0005773 | vacuole | H000633_01 | Coronin, actin-binding protein, 1A | D44497 | 109606 | CORO1A | 0.945 | 0.24739 |
303 | 0005773 | vacuole | H008567_01 | Sialidase 1 (lysosomal sialidase) | AF040958 | 118721 | NEU1 | 0.833 | 0.01207 |
304 | 0005773 | vacuole | H009939_01 | Hypothetical protein | AF151020 | 181444 | LOC51235 | 1.017 | 0.74195 |
305 | 0005773 | vacuole | H000751_01 | Anti-oxidant protein 2 (non-selenium glutathione peroxidase, acidic calcium-independent phospholipas |
D14662 | 120 | KIAA0106 | 1.121 | 0.08672 |
306 | 0005773 | vacuole | H010783_01 | Palmitoyl-protein thioesterase 2 | AF020544 | 81737 | PPT2 | 0.999 | 0.99101 |
307 | 0005773 | vacuole | H000868_01 | Mannosidase, beta A, lysosomal | U60337 | 115945 | MANBA | 0.922 | 0.19365 |
308 | 0005773 | vacuole | H000877_01 | Sphingomyelin phosphodiesterase 1, acid lysosomal (acid sphingomyelinase) |
X59960 | 77813 | SMPD1 | 0.93 | 0.19544 |
309 | 0005773 | vacuole | H000879_01 | Chitobiase, di-N-acetyl- | M95767 | 135578 | CTBS | 0.907 | 0.15643 |
310 | 0005773 | vacuole | H012397_01 | ESTs | X78261 | 272177 | 1.028 | 0.65963 | |
311 | 0005773 | vacuole | H000887_01 | Prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy) |
J03077 | 78575 | PSAP | 0.85 | 0.03087 |
312 | 0005773 | vacuole | H012727_01 | Cathepsin F | NM_003793 | 11590 | CTSF | 0.993 | 0.93097 |
313 | 0005773 | vacuole | H000926_01 | Transmembrane 4 superfamily member 3 | M35252 | 84072 | TM4SF3 | 1.04 | 0.49676 |
314 | 0005773 | vacuole | H000932_01 | N-sulfoglucosamine sulfohydrolase (sulfamidase) | U30894 | 31074 | SGSH | 0.929 | 0.35523 |
315 | 0005773 | vacuole | H014980_01 | Glucosidase, beta; acid (includes glucosylceramidase) | NM_000157 | 282997 | GBA | 0.882 | 0.09493 |
316 | 0005773 | vacuole | H001062_01 | N-acylsphingosine amidohydrolase (acid ceramidase) | U70063 | 75811 | ASAH | 0.761 | 0.00155 |
317 | 0005773 | vacuole | H001066_01 | Fucosidase, alpha-L- 1, tissue | M29877 | 576 | FUCA1 | 0.914 | 0.19066 |
318 | 0005773 | vacuole | H015633_01 | GM2 ganglioside activator protein | NM_000405 | 289082 | GM2A | 1.007 | 0.91285 |
319 | 0005773 | vacuole | H015696_01 | Cathepsin B | NM_001908 | 297939 | CTSB | 0.918 | 0.30063 |
320 | 0005773 | vacuole | H001083_01 | Low density lipoprotein-related protein 2 | U33837 | 153595 | LRP2 | 0.925 | 0.20154 |
321 | 0005773 | vacuole | H001085_01 | Mannosidase, alpha, class 2B, member 1 | U68382 | 279854 | MAN2B1 | 1.039 | 0.56235 |
322 | 0005773 | vacuole | H001116_01 | Steroid sulfatase (microsomal), arylsulfatase C, isozyme S | M16505 | 79876 | STS | 0.812 | 0.00508 |
323 | 0005773 | vacuole | H001148_01 | Galactosylceramidase (Krabbe disease) | NM_000153 | 273 | GALC | 0.883 | 0.0751 |
324 | 0005773 | vacuole | H001177_01 | Palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile) |
U44772 | 3873 | PPT1 | 0.987 | 0.84861 |
325 | 0005773 | vacuole | H001185_01 | Arylsulfatase A | NM_000487 | 88251 | ARSA | 0.904 | 0.14918 |
326 | 0006690 | icosanoid metabolism | H001509_01 | Aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) |
D17793 | 78183 | AKR1C3 | 0.465 | 3e-05 |
327 | 0006690 | icosanoid metabolism | H001543_01 | Cytochrome P450, subfamily IIJ (arachidonic acid epoxygenase) polypeptide 2 |
U37143 | 152096 | CYP2J2 | 1.006 | 0.93641 |
328 | 0006690 | icosanoid metabolism | H001562_01 | Hydroxyprostaglandin dehydrogenase 15-(NAD) | L76465 | 77348 | HPGD | 1.042 | 0.50286 |
329 | 0006690 | icosanoid metabolism | H001773_01 | Leukotriene A4 hydrolase | J03459 | 81118 | LTA4H | 1.061 | 0.16921 |
330 | 0006690 | icosanoid metabolism | H001846_01 | Unactive progesterone receptor, 23 kD | L24804 | 278270 | P23 | 0.825 | 0.05398 |
331 | 0006690 | icosanoid metabolism | H003299_01 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
M59979 | 88474 | PTGS1 | 1.394 | 0.00734 |
332 | 0006690 | icosanoid metabolism | H003774_01 | Phospholipase A2, group IVA (cytosolic, calcium-dependent) | M72393 | 211587 | PLA2G4A | 0.854 | 0.04496 |
333 | 0006690 | icosanoid metabolism | H000390_01 | Microsomal glutathione S-transferase 2 | U77604 | 81874 | MGST2 | 1.203 | 0.02993 |
334 | 0006690 | icosanoid metabolism | H006848_01 | Prostaglandin D2 synthase (21kD, brain) | NM_000954 | 8272 | PTGDS | 0.872 | 0.10275 |
335 | 0006690 | icosanoid metabolism | H011138_01 | Arachidonate 12-lipoxygenase, 12R type | AF038461 | 136574 | ALOX12B | 0.981 | 0.77087 |
336 | 0006690 | icosanoid metabolism | H001135_01 | Gamma-glutamyltransferase-like activity 1 | AL117414 | 1675 | GGTLA1 | 1.032 | 0.53679 |
337 | 0006000 | fructose metabolism | H001385_01 | Phosphofructokinase, liver | X15573 | 155455 | PFKL | 1.053 | 0.23567 |
338 | 0006000 | fructose metabolism | H003374_01 | Aldolase A, fructose-bisphosphate | M11560 | 273415 | ALDOA | 1.008 | 0.86656 |
339 | 0006000 | fructose metabolism | H004823_01 | Aldolase C, fructose-bisphosphate | AF054987 | 155247 | ALDOC | 0.954 | 0.4786 |
340 | 0006000 | fructose metabolism | H005445_01 | Homo sapiens clone 25028 mRNA sequence | AF131846 | 13396 | 0.874 | 0.03765 | |
341 | 0006000 | fructose metabolism | H005940_01 | Glutamine-fructose-6-phosphate transaminase 1 | M90516 | 1674 | GFPT1 | 1.108 | 0.25479 |
342 | 0006000 | fructose metabolism | H007211_01 | Glutamine-fructose-6-phosphate transaminase 2 | AB016789 | 30332 | GFPT2 | 0.825 | 0.09538 |
343 | 0006000 | fructose metabolism | H007688_01 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | AF109735 | 195471 | PFKFB3 | 1.453 | 0 |
344 | 0006000 | fructose metabolism | H011651_01 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | X52638 | 739 | PFKFB1 | 1.023 | 0.6794 |
345 | 0009986 | cell surface | H001650_01 | Chloride channel 3 | X78520 | 174139 | CLCN3 | 0.973 | 0.66948 |
346 | 0009986 | cell surface | H002338_01 | Fibroblast growth factor 10 | U67918 | 248049 | FGF10 | 1.018 | 0.84482 |
347 | 0009986 | cell surface | H005818_01 | KIAA1077 protein | AB029000 | 70823 | KIAA1077 | 0.94 | 0.74856 |
348 | 0009986 | cell surface | H006086_01 | Notch (Drosophila) homolog 2 | AL133036 | 8121 | NOTCH2 | 0.988 | 0.86836 |
349 | 0009986 | cell surface | H009347_01 | Neuronal cell adhesion molecule | AB002341 | 7912 | NRCAM | 0.584 | 1e-05 |
350 | 0009986 | cell surface | H010125_01 | Similar to glucosamine-6-sulfatases | AB033073 | 43857 | KIAA1247 | 0.865 | 0.09813 |
351 | 0009986 | cell surface | H016122_01 | TMTSP for transmembrane molecule with thrombospondin module | NM_018676 | 325667 | LOC55901 | 1.313 | 0.00083 |
352 | 0007411 | axon guidance | H003652_01 | Apolipoprotein E | M12529 | 169401 | APOE | 1.005 | 0.94163 |
353 | 0007411 | axon guidance | H000396_01 | Fasciculation and elongation protein zeta 1 (zygin I) | U60060 | 79226 | FEZ1 | 0.935 | 0.23095 |
354 | 0007411 | axon guidance | H004459_01 | Spondin 2, extracellular matrix protein | NM_012445 | 288126 | SPON2 | 0.926 | 0.37302 |
355 | 0007411 | axon guidance | H009347_01 | Neuronal cell adhesion molecule | AB002341 | 7912 | NRCAM | 0.584 | 1e-05 |
356 | 0007411 | axon guidance | H010897_01 | DKFZP434H168 protein | AL117580 | 241431 | DKFZP434H168 | 0.862 | 0.01431 |
357 | 0007411 | axon guidance | H000901_01 | Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
U28369 | 82222 | SEMA3B | 0.921 | 0.24356 |
358 | 0007411 | axon guidance | H013086_01 | Oligophrenin 1 | AJ001189 | 128824 | OPHN1 | 1.059 | 0.43883 |
359 | 0007411 | axon guidance | H015948_01 | Homo sapiens cDNA: FLJ22401 fis, clone HRC08032, highly similar to AB027466 Homo sapiens SPON2 mRNA |
AK024499 | 306919 | 0.785 | 0.01505 | |
360 | 0007411 | axon guidance | H001239_01 | Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (se |
AB021292 | 25887 | SEMA4F | 0.972 | 0.6257 |
361 | 0006665 | sphingolipid metabolism | H001450_01 | Globotriaosylceramide/CD77 synthase; Gb3/CD77 synthase; alpha1,4-galactosyltransferase; 4-N-acetylgl |
NM_017436 | 105956 | A14GALT | 0.933 | 0.31929 |
362 | 0006665 | sphingolipid metabolism | H000025_01 | Neutral sphingomyelinase (N-SMase) activation associated factor |
X96586 | 78687 | NSMAF | 0.742 | 0.00058 |
363 | 0006665 | sphingolipid metabolism | H003235_01 | GM2 ganglioside activator protein | X62078 | 69743 | GM2A | 0.957 | 0.41765 |
364 | 0006665 | sphingolipid metabolism | H004193_01 | Sialyltransferase 9 (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase; GM3 synthase) |
AB018356 | 225939 | SIAT9 | 0.814 | 0.06525 |
365 | 0006665 | sphingolipid metabolism | H000464_01 | Protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform |
M65254 | 108705 | PPP2R1B | 0.937 | 0.24318 |
366 | 0006665 | sphingolipid metabolism | H008553_01 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | AB022017 | 9247 | PRKAA1 | 1.089 | 0.15692 |
367 | 0006665 | sphingolipid metabolism | H000076_01 | UDP-glucose ceramide glucosyltransferase | D50840 | 152601 | UGCG | 0.81 | 0.01527 |
368 | 0006665 | sphingolipid metabolism | H000877_01 | Sphingomyelin phosphodiesterase 1, acid lysosomal (acid sphingomyelinase) |
X59960 | 77813 | SMPD1 | 0.93 | 0.19544 |
369 | 0006665 | sphingolipid metabolism | H000887_01 | Prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy) |
J03077 | 78575 | PSAP | 0.85 | 0.03087 |
370 | 0006665 | sphingolipid metabolism | H001022_01 | UDP glycosyltransferase 8 (UDP-galactose ceramide galactosyltransferase) |
U30930 | 158540 | UGT8 | 0.898 | 0.18479 |
371 | 0006665 | sphingolipid metabolism | H014980_01 | Glucosidase, beta; acid (includes glucosylceramidase) | NM_000157 | 282997 | GBA | 0.882 | 0.09493 |
372 | 0006665 | sphingolipid metabolism | H001062_01 | N-acylsphingosine amidohydrolase (acid ceramidase) | U70063 | 75811 | ASAH | 0.761 | 0.00155 |
373 | 0006665 | sphingolipid metabolism | H015633_01 | GM2 ganglioside activator protein | NM_000405 | 289082 | GM2A | 1.007 | 0.91285 |
374 | 0006665 | sphingolipid metabolism | H015734_01 | Sphingosine kinase type 2 isoform | AL136701 | 301305 | SPHK2 | 1.009 | 0.87246 |
375 | 0006665 | sphingolipid metabolism | H016485_01 | Sphingosine kinase 1 | NM_021972 | 68061 | SPHK1 | 1.013 | 0.883 |
376 | 0006665 | sphingolipid metabolism | H001148_01 | Galactosylceramidase (Krabbe disease) | NM_000153 | 273 | GALC | 0.883 | 0.0751 |
377 | 0006665 | sphingolipid metabolism | H001185_01 | Arylsulfatase A | NM_000487 | 88251 | ARSA | 0.904 | 0.14918 |
378 | 0004028 | aldehyde dehydrogenase activity | H001508_01 | Aldehyde dehydrogenase 4 family, member A1 | U24266 | 77448 | ALDH4A1 | 1.071 | 0.21045 |
379 | 0004028 | aldehyde dehydrogenase activity | H001525_01 | Aldehyde dehydrogenase 7 family, member A1 | S74728 | 74294 | ALDH7A1 | 1.065 | 0.29052 |
380 | 0004028 | aldehyde dehydrogenase activity | H001547_01 | Aldehyde dehydrogenase 3 family, member A1 | M74542 | 575 | ALDH3A1 | 1.208 | 0.02494 |
381 | 0004028 | aldehyde dehydrogenase activity | H001572_01 | Aldehyde dehydrogenase 3 family, member B2 | U37519 | 87539 | ALDH3B2 | 1.047 | 0.51127 |
382 | 0004028 | aldehyde dehydrogenase activity | H002609_01 | Aldehyde dehydrogenase 3 family, member B1 | U10868 | 83155 | ALDH3B1 | 0.893 | 0.05664 |
383 | 0004028 | aldehyde dehydrogenase activity | H002656_01 | Aldehyde dehydrogenase 9 family, member A1 | U34252 | 2533 | ALDH9A1 | 0.971 | 0.54467 |
384 | 0004028 | aldehyde dehydrogenase activity | H003022_01 | Aldehyde dehydrogenase 1 family, member A3 | U07919 | 75746 | ALDH1A3 | 0.641 | 0.01304 |
385 | 0004028 | aldehyde dehydrogenase activity | H003659_01 | Aldehyde dehydrogenase 3 family, member A2 | U46689 | 159608 | ALDH3A2 | 0.939 | 0.45817 |
386 | 0004028 | aldehyde dehydrogenase activity | H003776_01 | Aldehyde dehydrogenase 2 family (mitochondrial) | X05409 | 195432 | ALDH2 | 1.249 | 7e-05 |
387 | 0005581 | collagen | H001909_01 | Collagen, type IV, alpha 2 | X05610 | 75617 | COL4A2 | 1.108 | 0.39407 |
388 | 0005581 | collagen | H001981_01 | Collagen, type VI, alpha 3 | X52022 | 80988 | COL6A3 | 1.173 | 0.0519 |
389 | 0005581 | collagen | H002090_01 | Collagen, type XVI, alpha 1 | M92642 | 26208 | COL16A1 | 0.927 | 0.27606 |
390 | 0005581 | collagen | H002160_01 | Collagen, type V, alpha 2 | Y14690 | 82985 | COL5A2 | 0.867 | 0.10761 |
391 | 0005581 | collagen | H002306_01 | Collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) |
X14420 | 119571 | COL3A1 | 0.907 | 0.39389 |
392 | 0005581 | collagen | H002647_01 | Collagen, type XV, alpha 1 | L25286 | 83164 | COL15A1 | 1.005 | 0.91556 |
393 | 0005581 | collagen | H002655_01 | Collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) |
L02870 | 1640 | COL7A1 | 1.553 | p < 1e-07 |
394 | 0005581 | collagen | H002759_01 | Collagen, type IV, alpha 6 | D21337 | 408 | COL4A6 | 1.025 | 0.70581 |
395 | 0005581 | collagen | H002915_01 | Collagen, type VIII, alpha 1 | X57527 | 114599 | COL8A1 | 1.092 | 0.38509 |
396 | 0005581 | collagen | H002994_01 | Collagen, type XVIII, alpha 1 | AF018081 | 78409 | COL18A1 | 1.757 | 8e-05 |
397 | 0005581 | collagen | H003072_01 | Collagen, type I, alpha 2 | J03464 | 179573 | COL1A2 | 0.954 | 0.62985 |
398 | 0005581 | collagen | H003413_01 | Lumican | U21128 | 79914 | LUM | 0.854 | 0.1425 |
399 | 0005581 | collagen | H003593_01 | Collagen, type VI, alpha 2 | AL096746 | 159263 | COL6A2 | 0.991 | 0.87376 |
400 | 0005581 | collagen | H004095_01 | Collagen, type V, alpha 3 | AF177941 | 235368 | COL5A3 | 1.07 | 0.41285 |
401 | 0005581 | collagen | H006623_01 | Homo sapiens clone HB-2 mRNA sequence | AF216077 | 48376 | 1.142 | 0.17143 | |
402 | 0005581 | collagen | H000717_01 | Collagen, type IX, alpha 3 | L41162 | 53563 | COL9A3 | 1.05 | 0.45955 |
403 | 0005581 | collagen | H000734_01 | Collagen, type XIV, alpha 1 (undulin) | Y11710 | 36131 | COL14A1 | 1.002 | 0.98122 |
404 | 0005581 | collagen | H000774_01 | Collagen, type VI, alpha 1 | X15880 | 108885 | COL6A1 | 1.005 | 0.94306 |
405 | 0005581 | collagen | H012686_01 | Collagen, type XIII, alpha 1 | NM_005203 | 211933 | COL13A1 | 1.064 | 0.5062 |
406 | 0005581 | collagen | H015060_01 | Smooth muscle cell-expressed and macrophage conditioned medium-induced protein smag-64 |
NM_020351 | 283100 | LOC57086 | 1.121 | 0.13171 |
407 | 0045664 | regulation of neuron differentiation | H000594_01 | STAT induced STAT inhibitor-2 | NM_003877 | 110776 | STATI2 | 1.151 | 0.02953 |
408 | 0045664 | regulation of neuron differentiation | H009347_01 | Neuronal cell adhesion molecule | AB002341 | 7912 | NRCAM | 0.584 | 1e-05 |
409 | 0045664 | regulation of neuron differentiation | H010570_01 | CGI-05 protein | NM_016408 | 306044 | LOC51654 | 0.988 | 0.8359 |
410 | 0045664 | regulation of neuron differentiation | H011007_01 | Hypothetical protein FLJ10867 | AL133161 | 32360 | FLJ10867 | 1.077 | 0.33347 |
411 | 0045664 | regulation of neuron differentiation | H012950_01 | Neuroligin 1 | AB028993 | 71132 | NLGN1 | 1.04 | 0.60029 |
412 | 0051094 | positive regulation of development | H002747_01 | CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) | U04343 | 27954 | CD86 | 1.044 | 0.58602 |
413 | 0051094 | positive regulation of development | H002920_01 | Nitric oxide synthase 2A (inducible, hepatocytes) | X73029 | 193788 | NOS2A | 0.964 | 0.62365 |
414 | 0051094 | positive regulation of development | H000594_01 | STAT induced STAT inhibitor-2 | NM_003877 | 110776 | STATI2 | 1.151 | 0.02953 |
415 | 0051094 | positive regulation of development | H009347_01 | Neuronal cell adhesion molecule | AB002341 | 7912 | NRCAM | 0.584 | 1e-05 |
416 | 0051094 | positive regulation of development | H012804_01 | KIAA0670 protein/acinus | NM_014977 | 227133 | KIAA0670 | 1.029 | 0.53851 |
417 | 0045597 | positive regulation of cell differentiation | H002747_01 | CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) | U04343 | 27954 | CD86 | 1.044 | 0.58602 |
418 | 0045597 | positive regulation of cell differentiation | H002920_01 | Nitric oxide synthase 2A (inducible, hepatocytes) | X73029 | 193788 | NOS2A | 0.964 | 0.62365 |
419 | 0045597 | positive regulation of cell differentiation | H000594_01 | STAT induced STAT inhibitor-2 | NM_003877 | 110776 | STATI2 | 1.151 | 0.02953 |
420 | 0045597 | positive regulation of cell differentiation | H009347_01 | Neuronal cell adhesion molecule | AB002341 | 7912 | NRCAM | 0.584 | 1e-05 |
421 | 0045597 | positive regulation of cell differentiation | H012804_01 | KIAA0670 protein/acinus | NM_014977 | 227133 | KIAA0670 | 1.029 | 0.53851 |
422 | 0008154 | actin polymerization and/or depolymerization | H002337_01 | Stromal cell-derived factor 1 | L36033 | 237356 | SDF1 | 1.223 | 0.07778 |
423 | 0008154 | actin polymerization and/or depolymerization | H000031_01 | Gelsolin (amyloidosis, Finnish type) | X04412 | 290070 | GSN | 1.01 | 0.86337 |
424 | 0008154 | actin polymerization and/or depolymerization | H003673_01 | NCK adaptor protein 1 | X17576 | 54589 | NCK1 | 0.815 | 0.01282 |
425 | 0008154 | actin polymerization and/or depolymerization | H004619_01 | Profilin 2 | AL096719 | 91747 | PFN2 | 1.165 | 0.07894 |
426 | 0008154 | actin polymerization and/or depolymerization | H005560_01 | WAS protein family, member 1 | D87459 | 75850 | WASF1 | 0.744 | 0.00067 |
427 | 0008154 | actin polymerization and/or depolymerization | H006859_01 | Actin-related protein 3-beta | AF023453 | 12887 | ARP3BETA | 0.984 | 0.81334 |
428 | 0008154 | actin polymerization and/or depolymerization | H010725_01 | Capping protein (actin filament), gelsolin-like | M94345 | 82422 | CAPG | 0.888 | 0.15506 |
429 | 0008154 | actin polymerization and/or depolymerization | H014805_01 | Wiskott-Aldrich syndrome protein interacting protein | NM_003387 | 24143 | WASPIP | 1.114 | 0.09014 |
430 | 0008645 | hexose transport | H001728_01 | Phosphoprotein enriched in astrocytes 15 | X86809 | 194673 | PEA15 | 0.88 | 0.07395 |
431 | 0008645 | hexose transport | H002308_01 | Solute carrier family 2 (facilitated glucose transporter), member 3 |
M20681 | 7594 | SLC2A3 | 0.837 | 0.00747 |
432 | 0008645 | hexose transport | H004625_01 | Homolog of mouse MAT-1 oncogene | L37385 | 278268 | HUMMAT1H | 0.905 | 0.11366 |
433 | 0008645 | hexose transport | H008553_01 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | AB022017 | 9247 | PRKAA1 | 1.089 | 0.15692 |
434 | 0008645 | hexose transport | H010794_01 | Solute carrier family 2, (facilitated glucose transporter) member 8 |
AJ245937 | 10574 | SLC2A8 | 1.065 | 0.21771 |
435 | 0008645 | hexose transport | H015891_01 | Solute carrier family 2 (facilitated glucose transporter), member 10 |
AF321240 | 305971 | SLC2A10 | 0.837 | 0.01643 |
436 | 0008645 | hexose transport | H016613_01 | Solute carrier family 2 (facilitated glucose transporter), member 9 |
NM_020041 | 95497 | SLC2A9 | 1.099 | 0.122 |
437 | 0015749 | monosaccharide transport | H001728_01 | Phosphoprotein enriched in astrocytes 15 | X86809 | 194673 | PEA15 | 0.88 | 0.07395 |
438 | 0015749 | monosaccharide transport | H002308_01 | Solute carrier family 2 (facilitated glucose transporter), member 3 |
M20681 | 7594 | SLC2A3 | 0.837 | 0.00747 |
439 | 0015749 | monosaccharide transport | H004625_01 | Homolog of mouse MAT-1 oncogene | L37385 | 278268 | HUMMAT1H | 0.905 | 0.11366 |
440 | 0015749 | monosaccharide transport | H008553_01 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | AB022017 | 9247 | PRKAA1 | 1.089 | 0.15692 |
441 | 0015749 | monosaccharide transport | H010794_01 | Solute carrier family 2, (facilitated glucose transporter) member 8 |
AJ245937 | 10574 | SLC2A8 | 1.065 | 0.21771 |
442 | 0015749 | monosaccharide transport | H015891_01 | Solute carrier family 2 (facilitated glucose transporter), member 10 |
AF321240 | 305971 | SLC2A10 | 0.837 | 0.01643 |
443 | 0015749 | monosaccharide transport | H016613_01 | Solute carrier family 2 (facilitated glucose transporter), member 9 |
NM_020041 | 95497 | SLC2A9 | 1.099 | 0.122 |
444 | 0015758 | glucose transport | H001728_01 | Phosphoprotein enriched in astrocytes 15 | X86809 | 194673 | PEA15 | 0.88 | 0.07395 |
445 | 0015758 | glucose transport | H002308_01 | Solute carrier family 2 (facilitated glucose transporter), member 3 |
M20681 | 7594 | SLC2A3 | 0.837 | 0.00747 |
446 | 0015758 | glucose transport | H004625_01 | Homolog of mouse MAT-1 oncogene | L37385 | 278268 | HUMMAT1H | 0.905 | 0.11366 |
447 | 0015758 | glucose transport | H008553_01 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | AB022017 | 9247 | PRKAA1 | 1.089 | 0.15692 |
448 | 0015758 | glucose transport | H010794_01 | Solute carrier family 2, (facilitated glucose transporter) member 8 |
AJ245937 | 10574 | SLC2A8 | 1.065 | 0.21771 |
449 | 0015758 | glucose transport | H015891_01 | Solute carrier family 2 (facilitated glucose transporter), member 10 |
AF321240 | 305971 | SLC2A10 | 0.837 | 0.01643 |
450 | 0015758 | glucose transport | H016613_01 | Solute carrier family 2 (facilitated glucose transporter), member 9 |
NM_020041 | 95497 | SLC2A9 | 1.099 | 0.122 |
451 | 0001871 | pattern binding | H001945_01 | CD14 antigen | X13334 | 75627 | CD14 | 0.884 | 0.1688 |
452 | 0001871 | pattern binding | H002047_01 | Transforming growth factor, beta receptor III (betaglycan, 300kD) |
L07594 | 79059 | TGFBR3 | 0.759 | 0.04091 |
453 | 0001871 | pattern binding | H002052_01 | Thrombospondin 2 | L12350 | 108623 | THBS2 | 0.88 | 0.14324 |
454 | 0001871 | pattern binding | H002068_01 | Thrombospondin 1 | X14787 | 87409 | THBS1 | 0.8 | 0.06406 |
455 | 0001871 | pattern binding | H002081_01 | Placental growth factor, vascular endothelial growth factor-related protein |
X54936 | 2894 | PGF | 0.967 | 0.66427 |
456 | 0001871 | pattern binding | H002117_01 | Apolipoprotein B (including Ag(x) antigen) | X04506 | 585 | APOB | 1.016 | 0.83969 |
457 | 0001871 | pattern binding | H002255_01 | Diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor) |
M60278 | 799 | DTR | 1.17 | 0.04855 |
458 | 0001871 | pattern binding | H002338_01 | Fibroblast growth factor 10 | U67918 | 248049 | FGF10 | 1.018 | 0.84482 |
459 | 0001871 | pattern binding | H002416_01 | Apolipoprotein H (beta-2-glycoprotein I) | M62839 | 1252 | APOH | 0.92 | 0.41415 |
460 | 0001871 | pattern binding | H002423_01 | Vascular endothelial growth factor B | U43368 | 78781 | VEGFB | 0.756 | 5e-04 |
461 | 0001871 | pattern binding | H002455_01 | Aggrecan 1 (chondroitin sulfate proteoglycan 1, large aggregating proteoglycan, antigen identified b |
NM_013227 | 2159 | AGC1 | 1.144 | 0.21683 |
462 | 0001871 | pattern binding | H002481_01 | fibroblast growth factor 2 (basic) | J04513 | 56066 | FGF2 | 0.926 | 0.38612 |
463 | 0001871 | pattern binding | H002643_01 | Low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associa |
M63959 | 75140 | LRPAP1 | 0.944 | 0.16274 |
464 | 0001871 | pattern binding | H002764_01 | Lipase, hepatic | X07228 | 9994 | LIPC | 0.916 | 0.25156 |
465 | 0001871 | pattern binding | H002800_01 | Connective tissue growth factor | X78947 | 75511 | CTGF | 0.876 | 0.33394 |
466 | 0001871 | pattern binding | H002937_01 | Fibronectin 1 | X02761 | 287820 | FN1 | 1.038 | 0.4994 |
467 | 0001871 | pattern binding | H000319_01 | Zinc finger protein 146 | X70394 | 301819 | ZNF146 | 1.007 | 0.91633 |
468 | 0001871 | pattern binding | H002997_01 | Vascular endothelial growth factor | AF022375 | 73793 | VEGF | 0.988 | 0.80629 |
469 | 0001871 | pattern binding | H003065_01 | Osteoblast specific factor 2 (fasciclin I-like) | D13666 | 136348 | OSF-2 | 0.735 | 0.1187 |
470 | 0001871 | pattern binding | H003296_01 | Hepatoma-derived growth factor (high-mobility group protein 1-like) |
D16431 | 89525 | HDGF | 0.919 | 0.14242 |
471 | 0001871 | pattern binding | H003524_01 | Vitronectin (serum spreading factor, somatomedin B, complement S-protein) |
X03168 | 2257 | VTN | 1.057 | 0.39236 |
472 | 0001871 | pattern binding | H003599_01 | Fibroblast growth factor 9 (glia-activating factor) | D14838 | 111 | FGF9 | 0.899 | 0.09819 |
473 | 0001871 | pattern binding | H003652_01 | Apolipoprotein E | M12529 | 169401 | APOE | 1.005 | 0.94163 |
474 | 0001871 | pattern binding | H006492_01 | Homo sapiens CD44 isoform RC (CD44) mRNA, complete cds | AF098641 | 306278 | 1.375 | 0.00024 | |
475 | 0001871 | pattern binding | H006775_01 | A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 1 |
AB037767 | 8230 | ADAMTS1 | 0.83 | 0.08206 |
476 | 0001871 | pattern binding | H000589_01 | Cysteine-rich, angiogenic inducer, 61 | Y11307 | 8867 | CYR61 | 0.972 | 0.71628 |
477 | 0001871 | pattern binding | H008128_01 | Midkine (neurite growth-promoting factor 2) | X55110 | 82045 | MDK | 0.882 | 0.11138 |
478 | 0001871 | pattern binding | H008330_01 | Lipase, endothelial | NM_006033 | 65370 | LIPG | 0.958 | 0.66293 |
479 | 0001871 | pattern binding | H009385_01 | Hypothetical protein DKFZp434E0321 | AL133021 | 8658 | FELL | 0.934 | 0.31156 |
480 | 0001871 | pattern binding | H000723_01 | Angio-associated, migratory cell protein | M95627 | 83347 | AAMP | 1.016 | 0.69353 |
481 | 0001871 | pattern binding | H010264_01 | Human transformation-related protein mRNA, 3' end | L24521 | 300705 | 1.079 | 0.10122 | |
482 | 0001871 | pattern binding | H000841_01 | Amyloid beta (A4) precursor-like protein 1 | U48437 | 74565 | APLP1 | 0.998 | 0.97187 |
483 | 0001871 | pattern binding | H000953_01 | Amiloride binding protein 1 (amine oxidase (copper-containing)) |
U11863 | 75741 | ABP1 | 0.91 | 0.08931 |
484 | 0001871 | pattern binding | H013962_01 | Latent transforming growth factor beta binding protein 4 | Y13622 | 85087 | LTBP4 | 1.075 | 0.29926 |
485 | 0001871 | pattern binding | H001073_01 | Thrombospondin 3 | L38969 | 169875 | THBS3 | 0.797 | 0.01708 |
486 | 0001871 | pattern binding | H015675_01 | Follistatin-like 1 | BC000055 | 296267 | FSTL1 | 0.888 | 0.06529 |
487 | 0001871 | pattern binding | H016066_01 | Homo sapiens mRNA for MSF-FN70 (FN gene) | AJ276395 | 321592 | 1.086 | 0.4075 | |
488 | 0001871 | pattern binding | H016437_01 | Hypothetical protein SBBI67 | NM_020393 | 58356 | LOC57115 | 0.931 | 0.16891 |
489 | 0001871 | pattern binding | H001163_01 | Cartilage linking protein 1 | U43328 | 2799 | CRTL1 | 0.649 | 0.0585 |
490 | 0001871 | pattern binding | H001337_01 | Homo sapiens mRNA; cDNA DKFZp586E0524 (from clone DKFZp586E0524) |
AL110153 | 326249 | 0.891 | 0.03193 | |
491 | 0005087 | Ran guanyl nucleotide exchange factor activity | H000401_01 | Chromosome condensation 1 | X12654 | 84746 | CHC1 | 1.109 | 0.06564 |
492 | 0005087 | Ran guanyl nucleotide exchange factor activity | H004699_01 | Chromosome condensation 1-like | AF060219 | 27007 | CHC1L | 0.911 | 0.18699 |
493 | 0005087 | Ran guanyl nucleotide exchange factor activity | H005580_01 | RNA, U17D small nucleolar | AJ006835 | 196769 | RNU17D | 1.19 | 0.01592 |
494 | 0005087 | Ran guanyl nucleotide exchange factor activity | H014346_01 | Homo sapiens cDNA FLJ12962 fis, clone NT2RP2005694, weakly similar to X-LINKED RETINITIS PIGMENTOSA |
AK023024 | 149391 | 1.172 | 0.01171 | |
495 | 0005087 | Ran guanyl nucleotide exchange factor activity | H014937_01 | KIAA1563 protein | AB046783 | 27669 | KIAA1563 | 0.879 | 0.13441 |
496 | 0030246 | carbohydrate binding | H002042_01 | Polycystic kidney disease 1 (autosomal dominant) | L33243 | 75813 | PKD1 | 0.945 | 0.20851 |
497 | 0030246 | carbohydrate binding | H002047_01 | Transforming growth factor, beta receptor III (betaglycan, 300kD) |
L07594 | 79059 | TGFBR3 | 0.759 | 0.04091 |
498 | 0030246 | carbohydrate binding | H002052_01 | Thrombospondin 2 | L12350 | 108623 | THBS2 | 0.88 | 0.14324 |
499 | 0030246 | carbohydrate binding | H002053_01 | CD72 antigen | M54992 | 116481 | CD72 | 0.982 | 0.74516 |
500 | 0030246 | carbohydrate binding | H002068_01 | Thrombospondin 1 | X14787 | 87409 | THBS1 | 0.8 | 0.06406 |
501 | 0030246 | carbohydrate binding | H002081_01 | Placental growth factor, vascular endothelial growth factor-related protein |
X54936 | 2894 | PGF | 0.967 | 0.66427 |
502 | 0030246 | carbohydrate binding | H002117_01 | Apolipoprotein B (including Ag(x) antigen) | X04506 | 585 | APOB | 1.016 | 0.83969 |
503 | 0030246 | carbohydrate binding | H002255_01 | Diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor) |
M60278 | 799 | DTR | 1.17 | 0.04855 |
504 | 0030246 | carbohydrate binding | H002338_01 | Fibroblast growth factor 10 | U67918 | 248049 | FGF10 | 1.018 | 0.84482 |
505 | 0030246 | carbohydrate binding | H002395_01 | Calnexin | L10284 | 155560 | CANX | 1.015 | 0.74622 |
506 | 0030246 | carbohydrate binding | H002416_01 | Apolipoprotein H (beta-2-glycoprotein I) | M62839 | 1252 | APOH | 0.92 | 0.41415 |
507 | 0030246 | carbohydrate binding | H002423_01 | Vascular endothelial growth factor B | U43368 | 78781 | VEGFB | 0.756 | 5e-04 |
508 | 0030246 | carbohydrate binding | H002455_01 | Aggrecan 1 (chondroitin sulfate proteoglycan 1, large aggregating proteoglycan, antigen identified b |
NM_013227 | 2159 | AGC1 | 1.144 | 0.21683 |
509 | 0030246 | carbohydrate binding | H002481_01 | fibroblast growth factor 2 (basic) | J04513 | 56066 | FGF2 | 0.926 | 0.38612 |
510 | 0030246 | carbohydrate binding | H002643_01 | Low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associa |
M63959 | 75140 | LRPAP1 | 0.944 | 0.16274 |
511 | 0030246 | carbohydrate binding | H002764_01 | Lipase, hepatic | X07228 | 9994 | LIPC | 0.916 | 0.25156 |
512 | 0030246 | carbohydrate binding | H002800_01 | Connective tissue growth factor | X78947 | 75511 | CTGF | 0.876 | 0.33394 |
513 | 0030246 | carbohydrate binding | H002931_01 | Selectin L (lymphocyte adhesion molecule 1) | M25280 | 82848 | SELL | 0.942 | 0.32569 |
514 | 0030246 | carbohydrate binding | H002937_01 | Fibronectin 1 | X02761 | 287820 | FN1 | 1.038 | 0.4994 |
515 | 0030246 | carbohydrate binding | H000319_01 | Zinc finger protein 146 | X70394 | 301819 | ZNF146 | 1.007 | 0.91633 |
516 | 0030246 | carbohydrate binding | H002997_01 | Vascular endothelial growth factor | AF022375 | 73793 | VEGF | 0.988 | 0.80629 |
517 | 0030246 | carbohydrate binding | H003065_01 | Osteoblast specific factor 2 (fasciclin I-like) | D13666 | 136348 | OSF-2 | 0.735 | 0.1187 |
518 | 0030246 | carbohydrate binding | H003289_01 | Killer cell lectin-like receptor subfamily D, member 1 | NM_002262 | 41682 | KLRD1 | 1.042 | 0.50408 |
519 | 0030246 | carbohydrate binding | H003296_01 | Hepatoma-derived growth factor (high-mobility group protein 1-like) |
D16431 | 89525 | HDGF | 0.919 | 0.14242 |
520 | 0030246 | carbohydrate binding | H003524_01 | Vitronectin (serum spreading factor, somatomedin B, complement S-protein) |
X03168 | 2257 | VTN | 1.057 | 0.39236 |
521 | 0030246 | carbohydrate binding | H003599_01 | Fibroblast growth factor 9 (glia-activating factor) | D14838 | 111 | FGF9 | 0.899 | 0.09819 |
522 | 0030246 | carbohydrate binding | H003652_01 | Apolipoprotein E | M12529 | 169401 | APOE | 1.005 | 0.94163 |
523 | 0030246 | carbohydrate binding | H003890_01 | Myelin associated glycoprotein | M29273 | 1780 | MAG | 1.197 | 0.00625 |
524 | 0030246 | carbohydrate binding | H004739_01 | DiGeorge syndrome gene D | L77561 | 83775 | DGS-D | 0.983 | 0.82507 |
525 | 0030246 | carbohydrate binding | H005212_01 | C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 2 (activation |
X96719 | 85201 | CLECSF2 | 1.001 | 0.99201 |
526 | 0030246 | carbohydrate binding | H005445_01 | Homo sapiens clone 25028 mRNA sequence | AF131846 | 13396 | 0.874 | 0.03765 | |
527 | 0030246 | carbohydrate binding | H005586_01 | Endoplasmic reticulum glycoprotein | U10362 | 75864 | GP36B | 0.988 | 0.82613 |
528 | 0030246 | carbohydrate binding | H005940_01 | Glutamine-fructose-6-phosphate transaminase 1 | M90516 | 1674 | GFPT1 | 1.108 | 0.25479 |
529 | 0030246 | carbohydrate binding | H006119_01 | C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 5 |
AJ271684 | 126355 | CLECSF5 | 1.033 | 0.56841 |
530 | 0030246 | carbohydrate binding | H000541_01 | Stem cell growth factor; lymphocyte secreted C-type lectin | AF020044 | 105927 | SCGF | 1.085 | 0.15994 |
531 | 0030246 | carbohydrate binding | H006492_01 | Homo sapiens CD44 isoform RC (CD44) mRNA, complete cds | AF098641 | 306278 | 1.375 | 0.00024 | |
532 | 0030246 | carbohydrate binding | H006775_01 | A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 1 |
AB037767 | 8230 | ADAMTS1 | 0.83 | 0.08206 |
533 | 0030246 | carbohydrate binding | H007165_01 | Collectin sub-family member 10 (C-type lectin) | AB002631 | 176615 | COLEC10 | 0.992 | 0.90126 |
534 | 0030246 | carbohydrate binding | H007211_01 | Glutamine-fructose-6-phosphate transaminase 2 | AB016789 | 30332 | GFPT2 | 0.825 | 0.09538 |
535 | 0030246 | carbohydrate binding | H000589_01 | Cysteine-rich, angiogenic inducer, 61 | Y11307 | 8867 | CYR61 | 0.972 | 0.71628 |
536 | 0030246 | carbohydrate binding | H008128_01 | Midkine (neurite growth-promoting factor 2) | X55110 | 82045 | MDK | 0.882 | 0.11138 |
537 | 0030246 | carbohydrate binding | H008262_01 | Lectomedin-2 | AB020628 | 107054 | KIAA0821 | 1.007 | 0.87272 |
538 | 0030246 | carbohydrate binding | H008301_01 | Sialic acid binding Ig-like lectin 7 | AJ007395 | 274470 | SIGLEC7 | 1.027 | 0.61102 |
539 | 0030246 | carbohydrate binding | H008330_01 | Lipase, endothelial | NM_006033 | 65370 | LIPG | 0.958 | 0.66293 |
540 | 0030246 | carbohydrate binding | H000672_01 | KIAA0022 gene product | D14664 | 2441 | KIAA0022 | 1.157 | 0.06571 |
541 | 0030246 | carbohydrate binding | H008650_01 | Endocytic receptor (macrophage mannose receptor family) | AB014609 | 7835 | KIAA0709 | 1.04 | 0.47157 |
542 | 0030246 | carbohydrate binding | H008709_01 | D-siglec precursor, | AF178981 | 149250 | LOC51766 | 1.19 | 0.00898 |
543 | 0030246 | carbohydrate binding | H009007_01 | Attractin | AF106861 | 194019 | ATRN | 1.113 | 0.09964 |
544 | 0030246 | carbohydrate binding | H009385_01 | Hypothetical protein DKFZp434E0321 | AL133021 | 8658 | FELL | 0.934 | 0.31156 |
545 | 0030246 | carbohydrate binding | H000715_01 | Phospholipase A2 receptor 1, 180kD | U17033 | 171945 | PLA2R1 | 1.128 | 0.15487 |
546 | 0030246 | carbohydrate binding | H000723_01 | Angio-associated, migratory cell protein | M95627 | 83347 | AAMP | 1.016 | 0.69353 |
547 | 0030246 | carbohydrate binding | H009608_01 | Absent in melanoma 1 | U83115 | 161002 | AIM1 | 1.366 | 0.03118 |
548 | 0030246 | carbohydrate binding | H009943_01 | Sialic acid binding Ig-like lectin 8 | NM_014442 | 279751 | SIGLEC8 | 1.01 | 0.86899 |
549 | 0030246 | carbohydrate binding | H010264_01 | Human transformation-related protein mRNA, 3' end | L24521 | 300705 | 1.079 | 0.10122 | |
550 | 0030246 | carbohydrate binding | H010933_01 | Lectin, galactoside-binding, soluble, 3 (galectin 3) | AB006780 | 621 | LGALS3 | 1.013 | 0.87132 |
551 | 0030246 | carbohydrate binding | H000813_01 | Tetranectin (plasminogen-binding protein) | X64559 | 65424 | TNA | 0.817 | 0.03798 |
552 | 0030246 | carbohydrate binding | H000841_01 | Amyloid beta (A4) precursor-like protein 1 | U48437 | 74565 | APLP1 | 0.998 | 0.97187 |
553 | 0030246 | carbohydrate binding | H011506_01 | Homo sapiens mRNA; cDNA DKFZp586F0824 (from clone DKFZp586F0824); partial cds |
AL137646 | 146001 | 0.794 | 0.05535 | |
554 | 0030246 | carbohydrate binding | H011742_01 | Killer cell lectin-like receptor F1 | AF175206 | 183125 | KLRF1 | 0.973 | 0.60636 |
555 | 0030246 | carbohydrate binding | H000953_01 | Amiloride binding protein 1 (amine oxidase (copper-containing)) |
U11863 | 75741 | ABP1 | 0.91 | 0.08931 |
556 | 0030246 | carbohydrate binding | H013962_01 | Latent transforming growth factor beta binding protein 4 | Y13622 | 85087 | LTBP4 | 1.075 | 0.29926 |
557 | 0030246 | carbohydrate binding | H000975_01 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) |
U41514 | 80120 | GALNT1 | 1.037 | 0.55496 |
558 | 0030246 | carbohydrate binding | H014626_01 | Tumor endothelial marker 1 precursor | NM_020404 | 195727 | TEM1 | 0.992 | 0.89021 |
559 | 0030246 | carbohydrate binding | H001073_01 | Thrombospondin 3 | L38969 | 169875 | THBS3 | 0.797 | 0.01708 |
560 | 0030246 | carbohydrate binding | H015675_01 | Follistatin-like 1 | BC000055 | 296267 | FSTL1 | 0.888 | 0.06529 |
561 | 0030246 | carbohydrate binding | H001093_01 | Asialoglycoprotein receptor 2 | X55284 | 1259 | ASGR2 | 0.881 | 0.06 |
562 | 0030246 | carbohydrate binding | H016066_01 | Homo sapiens mRNA for MSF-FN70 (FN gene) | AJ276395 | 321592 | 1.086 | 0.4075 | |
563 | 0030246 | carbohydrate binding | H001163_01 | Cartilage linking protein 1 | U43328 | 2799 | CRTL1 | 0.649 | 0.0585 |
564 | 0030246 | carbohydrate binding | H001238_01 | Asialoglycoprotein receptor 1 | M10058 | 12056 | ASGR1 | 0.974 | 0.63722 |
565 | 0030246 | carbohydrate binding | H001257_01 | DiGeorge syndrome critical region gene 2 | D79985 | 2491 | DGCR2 | 0.966 | 0.49242 |
566 | 0030246 | carbohydrate binding | H001337_01 | Homo sapiens mRNA; cDNA DKFZp586E0524 (from clone DKFZp586E0524) |
AL110153 | 326249 | 0.891 | 0.03193 | |
567 | 0030166 | proteoglycan biosynthesis | H004560_01 | Heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 | NM_006041 | 159572 | HS3ST3B1 | 1.102 | 0.12948 |
568 | 0030166 | proteoglycan biosynthesis | H011024_01 | KIAA0836 protein | AB020643 | 183006 | KIAA0836 | 0.901 | 0.11901 |
569 | 0030166 | proteoglycan biosynthesis | H000873_01 | N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 | U18932 | 20894 | NDST1 | 0.848 | 0.0317 |
570 | 0030166 | proteoglycan biosynthesis | H014535_01 | Hypothetical protein PRO0082 | NM_018590 | 180758 | PRO0082 | 0.903 | 0.22169 |
571 | 0030166 | proteoglycan biosynthesis | H014852_01 | Chondroitin 4-O-sulfotransferase 2 | NM_018641 | 25204 | C4S-2 | 1.082 | 0.08933 |
572 | 0008047 | enzyme activator activity | H001587_01 | GDP dissociation inhibitor 1 | X79353 | 74576 | GDI1 | 1.078 | 0.10423 |
573 | 0008047 | enzyme activator activity | H001600_01 | RAS p21 protein activator (GTPase activating protein) 1 | M23379 | 758 | RASA1 | 1.159 | 0.03328 |
574 | 0008047 | enzyme activator activity | H001612_01 | RAP1, GTP-GDP dissociation stimulator 1 | AF237413 | 7940 | RAP1GDS1 | 0.845 | 0.00358 |
575 | 0008047 | enzyme activator activity | H001635_01 | GDP dissociation inhibitor 2 | Y13286 | 56845 | GDI2 | 1.065 | 0.19057 |
576 | 0008047 | enzyme activator activity | H001668_01 | Secretory granule, neuroendocrine protein 1 (7B2 protein) | Y00757 | 2265 | SGNE1 | 1.036 | 0.74881 |
577 | 0008047 | enzyme activator activity | H001717_01 | RAP1, GTPase activating protein 1 | M64788 | 75151 | RAP1GA1 | 0.904 | 0.22222 |
578 | 0008047 | enzyme activator activity | H001752_01 | Ran GTPase activating protein 1 | X82260 | 183800 | RANGAP1 | 1.12 | 0.29546 |
579 | 0008047 | enzyme activator activity | H001881_01 | Proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
D45248 | 179774 | PSME2 | 1.109 | 0.08468 |
580 | 0008047 | enzyme activator activity | H001975_01 | Rho GDP dissociation inhibitor (GDI) beta | L20688 | 83656 | ARHGDIB | 1.056 | 0.5118 |
581 | 0008047 | enzyme activator activity | H000256_01 | IQ motif containing GTPase activating protein 2 | U51903 | 78993 | IQGAP2 | 0.995 | 0.93649 |
582 | 0008047 | enzyme activator activity | H002535_01 | Rho GDP dissociation inhibitor (GDI) alpha | X69550 | 159161 | ARHGDIA | 1.048 | 0.31969 |
583 | 0008047 | enzyme activator activity | H002630_01 | Rho GTPase activating protein 1 | U02570 | 138860 | ARHGAP1 | 0.899 | 0.14521 |
584 | 0008047 | enzyme activator activity | H000294_01 | Deleted in liver cancer 1 | AF035119 | 8700 | DLC1 | 0.955 | 0.53925 |
585 | 0008047 | enzyme activator activity | H003045_01 | Tumor necrosis factor receptor superfamily, member 10b | AF016266 | 51233 | TNFRSF10B | 0.97 | 0.5882 |
586 | 0008047 | enzyme activator activity | H003235_01 | GM2 ganglioside activator protein | X62078 | 69743 | GM2A | 0.957 | 0.41765 |
587 | 0008047 | enzyme activator activity | H003264_01 | Caspase 9, apoptosis-related cysteine protease | U60521 | 100641 | CASP9 | 0.979 | 0.7713 |
588 | 0008047 | enzyme activator activity | H003339_01 | Heat shock 27kD protein 2 | D89617 | 78846 | HSPB2 | 0.933 | 0.25345 |
589 | 0008047 | enzyme activator activity | H003366_01 | Rho GTPase activating protein 4 | X78817 | 3109 | ARHGAP4 | 0.956 | 0.53411 |
590 | 0008047 | enzyme activator activity | H003392_01 | Matrix metalloproteinase 15 (membrane-inserted) | Z48482 | 80343 | MMP15 | 0.953 | 0.57585 |
591 | 0008047 | enzyme activator activity | H003441_01 | Breakpoint cluster region | X02596 | 234799 | BCR | 0.978 | 0.70681 |
592 | 0008047 | enzyme activator activity | H003632_01 | Neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) |
M89914 | 93207 | NF1 | 1.098 | 0.09468 |
593 | 0008047 | enzyme activator activity | H000035_01 | Apoptosis-associated speck-like protein containing a CARD | NM_013258 | 71869 | ASC | 1.226 | 0.01397 |
594 | 0008047 | enzyme activator activity | H003757_01 | MAP-kinase activating death domain | U77352 | 82548 | MADD | 1.184 | 0.06185 |
595 | 0008047 | enzyme activator activity | H000390_01 | Microsomal glutathione S-transferase 2 | U77604 | 81874 | MGST2 | 1.203 | 0.02993 |
596 | 0008047 | enzyme activator activity | H000411_01 | Regulator of G-protein signalling 19 | X91809 | 22698 | RGS19 | 0.882 | 0.04412 |
597 | 0008047 | enzyme activator activity | H004200_01 | Death effector filament-forming Ced-4-like apoptosis protein | AB023143 | 104305 | DEFCAP | 0.943 | 0.34662 |
598 | 0008047 | enzyme activator activity | H000412_01 | Regulator of G-protein signalling 14 | AF037195 | 9347 | RGS14 | 1.025 | 0.65334 |
599 | 0008047 | enzyme activator activity | H004224_01 | Hypothetical protein FLJ10767 | AK001629 | 25584 | FLJ10767 | 1.127 | 0.09385 |
600 | 0008047 | enzyme activator activity | H004296_01 | Matrix metalloproteinase 24 (membrane-inserted) | AB021227 | 3743 | MMP24 | 0.999 | 0.99235 |
601 | 0008047 | enzyme activator activity | H004551_01 | Metalloprotease 1 (pitrilysin family) | AK002061 | 260116 | MP1 | 1.1 | 0.12264 |
602 | 0008047 | enzyme activator activity | H004598_01 | Hypothetical protein PP1044 | AF131825 | 7212 | PP1044 | 1.269 | 0.01003 |
603 | 0008047 | enzyme activator activity | H000440_01 | Regulator of G-protein signalling 3 | U27655 | 82294 | RGS3 | 1.032 | 0.6932 |
604 | 0008047 | enzyme activator activity | H000446_01 | Proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
L07633 | 75348 | PSME1 | 0.898 | 0.05819 |
605 | 0008047 | enzyme activator activity | H004890_01 | PDZ domain containing guanine nucleotide exchange factor(GEF)1 | AB002311 | 154545 | PDZ-GEF1 | 0.973 | 0.67067 |
606 | 0008047 | enzyme activator activity | H004895_01 | Hypothetical protein FLJ11323 | AK002185 | 25625 | FLJ11323 | 1.069 | 0.2911 |
607 | 0008047 | enzyme activator activity | H000475_01 | Apoptotic protease activating factor | NM_013229 | 77579 | APAF1 | 1.008 | 0.87839 |
608 | 0008047 | enzyme activator activity | H006228_01 | Deleted in liver cancer 1 | AL117604 | 8700 | DLC1 | 0.916 | 0.21322 |
609 | 0008047 | enzyme activator activity | H006485_01 | Protein kinase, interferon-inducible double stranded RNA dependent activator |
AF072860 | 18571 | PRKRA | 0.901 | 0.10102 |
610 | 0008047 | enzyme activator activity | H006648_01 | PTPL1-associated RhoGAP 1 | U90920 | 70983 | PARG1 | 1.094 | 0.45938 |
611 | 0008047 | enzyme activator activity | H006668_01 | RAS p21 protein activator (GTPase activating protein) 3 (Ins(1,3,4,5)P4-binding protein) |
X89399 | 119274 | RASA3 | 1.023 | 0.70325 |
612 | 0008047 | enzyme activator activity | H006707_01 | Development and differentiation enhancing factor 2 | AB007860 | 12802 | DDEF2 | 1.221 | 0.01623 |
613 | 0008047 | enzyme activator activity | H006855_01 | KIAA1108 protein | AB029031 | 278586 | KIAA1108 | 1.079 | 0.30292 |
614 | 0008047 | enzyme activator activity | H007032_01 | BCL2/adenovirus E1B 19kD-interacting protein 2 | U15173 | 155596 | BNIP2 | 0.949 | 0.32291 |
615 | 0008047 | enzyme activator activity | H007037_01 | Regulator of G-protein signalling 6 | AF073920 | 3221 | RGS6 | 1.115 | 0.19727 |
616 | 0008047 | enzyme activator activity | H000584_01 | Regulator of G-protein signalling 4 | U27768 | 227571 | RGS4 | 0.92 | 0.29059 |
617 | 0008047 | enzyme activator activity | H007196_01 | General transcription factor IIIC, polypeptide 4 (90kD) | NM_012204 | 22302 | GTF3C4 | 1.011 | 0.85743 |
618 | 0008047 | enzyme activator activity | H000587_01 | Ubiquitin-activating enzyme E1-like | L13852 | 16695 | UBE1L | 0.971 | 0.65943 |
619 | 0008047 | enzyme activator activity | H007392_01 | ADP-ribosylation factor 5 | M57567 | 77541 | ARF5 | 1.029 | 0.52757 |
620 | 0008047 | enzyme activator activity | H007564_01 | Caspase recruitment domain 4 | NM_006092 | 19405 | NOD1 | 0.94 | 0.28814 |
621 | 0008047 | enzyme activator activity | H007827_01 | Rho guanine exchange factor (GEF) 11 | AB002378 | 47822 | ARHGEF11 | 0.963 | 0.50601 |
622 | 0008047 | enzyme activator activity | H008350_01 | Myosin phosphatase, target subunit 2 | AB007972 | 130760 | MYPT2 | 0.895 | 0.27031 |
623 | 0008047 | enzyme activator activity | H008446_01 | KIAA0167 gene product | D79989 | 184884 | KIAA0167 | 0.973 | 0.64609 |
624 | 0008047 | enzyme activator activity | H008518_01 | Estrogen receptor binding site associated, antigen, 9 | AB007619 | 9222 | EBAG9 | 1.055 | 0.44919 |
625 | 0008047 | enzyme activator activity | H008553_01 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | AB022017 | 9247 | PRKAA1 | 1.089 | 0.15692 |
626 | 0008047 | enzyme activator activity | H000680_01 | Active BCR-related gene | U01147 | 118021 | ABR | 0.879 | 0.02186 |
627 | 0008047 | enzyme activator activity | H008771_01 | MIL1 protein | NM_015367 | 10267 | MIL1 | 0.875 | 0.08726 |
628 | 0008047 | enzyme activator activity | H000687_01 | Apolipoprotein C-II | NM_000483 | 75615 | APOC2 | 1.016 | 0.80834 |
629 | 0008047 | enzyme activator activity | H009484_01 | G protein-coupled receptor kinase-interactor 1 | NM_014030 | 318339 | GIT1 | 1.067 | 0.32333 |
630 | 0008047 | enzyme activator activity | H009941_01 | Rho GTPase activating protein 1 | U62794 | 138860 | ARHGAP1 | 1.013 | 0.88343 |
631 | 0008047 | enzyme activator activity | H010039_01 | Tuberous sclerosis 2 | X75621 | 90303 | TSC2 | 0.954 | 0.5158 |
632 | 0008047 | enzyme activator activity | H010766_01 | Glia maturation factor, gamma | AB001993 | 5210 | GMFG | 1.179 | 0.13646 |
633 | 0008047 | enzyme activator activity | H010923_01 | Regulator of G-protein signalling 11 | NM_003834 | 65756 | RGS11 | 0.905 | 0.17547 |
634 | 0008047 | enzyme activator activity | H011078_01 | Chimerin (chimaerin) 1 | X51408 | 169965 | CHN1 | 0.769 | 0.00978 |
635 | 0008047 | enzyme activator activity | H011501_01 | ADP-ribosylation factor 4 | NM_001660 | 75290 | ARF4 | 0.845 | 0.02658 |
636 | 0008047 | enzyme activator activity | H011986_01 | DKFZP727I051 protein | AL117478 | 239370 | DKFZP727I051 | 1.08 | 0.28838 |
637 | 0008047 | enzyme activator activity | H011998_01 | Centaurin-alpha 2 protein | AJ272195 | 28802 | HSA272195 | 0.999 | 0.9876 |
638 | 0008047 | enzyme activator activity | H012025_01 | Homo sapiens cDNA FLJ10023 fis, clone HEMBA1000608, moderately similar to HYPOTHETICAL PROTEIN KIAA0 |
AK000885 | 306413 | 0.961 | 0.63648 | |
639 | 0008047 | enzyme activator activity | H000887_01 | Prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy) |
J03077 | 78575 | PSAP | 0.85 | 0.03087 |
640 | 0008047 | enzyme activator activity | H012654_01 | Cdc42 effector protein 2 | AF001436 | 12289 | CEP2 | 0.859 | 0.08372 |
641 | 0008047 | enzyme activator activity | H012678_01 | RalA binding protein 1 | L42542 | 75447 | RALBP1 | 0.945 | 0.30959 |
642 | 0008047 | enzyme activator activity | H013086_01 | Oligophrenin 1 | AJ001189 | 128824 | OPHN1 | 1.059 | 0.43883 |
643 | 0008047 | enzyme activator activity | H013206_01 | ADP-ribosylation factor GTPase activating protein 1 | AF111847 | 13014 | ARFGAP1 | 1.202 | 0.09399 |
644 | 0008047 | enzyme activator activity | H013355_01 | Meningioma expressed antigen 6 (coiled-coil proline-rich) | U94780 | 117242 | MGEA6 | 0.918 | 0.15887 |
645 | 0008047 | enzyme activator activity | H013770_01 | Colipase, pancreatic | J02883 | 1340 | CLPS | 0.98 | 0.81059 |
646 | 0008047 | enzyme activator activity | H014008_01 | Homo sapiens mRNA; cDNA DKFZp434P2235 (from clone DKFZp434P2235); complete cds |
AL136860 | 105891 | 0.93 | 0.3587 | |
647 | 0008047 | enzyme activator activity | H014216_01 | Hypothetical protein similar to mouse Dnajl1 | NM_022365 | 13015 | DNAJL1 | 0.939 | 0.31485 |
648 | 0008047 | enzyme activator activity | H014530_01 | Hypothetical protein FLJ22439 | NM_024832 | 180040 | FLJ22439 | 1.182 | 0.05692 |
649 | 0008047 | enzyme activator activity | H015517_01 | Chromosome 6 open reading frame 9 | NM_022107 | 288316 | C6ORF9 | 1.12 | 0.0883 |
650 | 0008047 | enzyme activator activity | H015633_01 | GM2 ganglioside activator protein | NM_000405 | 289082 | GM2A | 1.007 | 0.91285 |
651 | 0008047 | enzyme activator activity | H000015_01 | Dedicator of cyto-kinesis 1 | D50857 | 82295 | DOCK1 | 0.995 | 0.95 |
652 | 0008047 | enzyme activator activity | H001274_01 | Regulator of G-protein signalling 2, 24kD | L13463 | 78944 | RGS2 | 0.911 | 0.12621 |
653 | 0015078 | hydrogen ion transporter activity | H001499_01 | Ubiquinol-cytochrome c reductase hinge protein | Y00764 | 73818 | UQCRH | 1.114 | 0.01812 |
654 | 0015078 | hydrogen ion transporter activity | H001510_01 | NADH dehydrogenase (ubiquinone) Fe-S protein 1 (75kD) (NADH-coenzyme Q reductase) |
X61100 | 8248 | NDUFS1 | 1.055 | 0.28624 |
655 | 0015078 | hydrogen ion transporter activity | H001513_01 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3 (12kD, B12) |
AF047183 | 109760 | NDUFB3 | 1.102 | 0.0437 |
656 | 0015078 | hydrogen ion transporter activity | H001514_01 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4 (15kD, B15) |
AF044957 | 227750 | NDUFB4 | 1.058 | 0.18971 |
657 | 0015078 | hydrogen ion transporter activity | H001526_01 | NADH dehydrogenase (ubiquinone) Fe-S protein 4 (18kD) (NADH-coenzyme Q reductase) |
AF020351 | 10758 | NDUFS4 | 1.029 | 0.52362 |
658 | 0015078 | hydrogen ion transporter activity | H001530_01 | NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 (14.5kD, B14.5b) |
AL050278 | 193313 | NDUFC2 | 1 | 0.99825 |
659 | 0015078 | hydrogen ion transporter activity | H001540_01 | NADH dehydrogenase (ubiquinone) Fe-S protein 5 (15kD) (NADH-coenzyme Q reductase) |
AF047434 | 80595 | NDUFS5 | 1.035 | 0.51566 |
660 | 0015078 | hydrogen ion transporter activity | H001544_01 | NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1 (6kD, KFYI) |
AF047184 | 84549 | NDUFC1 | 1.084 | 0.06377 |
661 | 0015078 | hydrogen ion transporter activity | H001551_01 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 (14kD, B14) |
AF047182 | 274416 | NDUFA6 | 1.088 | 0.09856 |
662 | 0015078 | hydrogen ion transporter activity | H001555_01 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (14.5kD, B14.5a) |
AF054178 | 19561 | NDUFA7 | 0.999 | 0.99 |
663 | 0015078 | hydrogen ion transporter activity | H001563_01 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 (13kD, B13) |
NM_005000 | 83916 | NDUFA5 | 0.934 | 0.19767 |
664 | 0015078 | hydrogen ion transporter activity | H001564_01 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 (9kD, B9) |
AF044955 | 198269 | NDUFA3 | 0.979 | 0.63748 |
665 | 0015078 | hydrogen ion transporter activity | H001565_01 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10 (42kD) | AF087661 | 198271 | NDUFA10 | 0.913 | 0.06739 |
666 | 0015078 | hydrogen ion transporter activity | H001566_01 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 (8kD, AGGG) |
AF050639 | 198272 | NDUFB2 | 1.036 | 0.45378 |
667 | 0015078 | hydrogen ion transporter activity | H001567_01 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8 (19kD, ASHI) |
AF044958 | 198273 | NDUFB8 | 1.025 | 0.54405 |
668 | 0015078 | hydrogen ion transporter activity | H001568_01 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10 (22kD, PDSW) |
AF088991 | 198274 | NDUFB10 | 1.039 | 0.30356 |
669 | 0015078 | hydrogen ion transporter activity | H001570_01 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 (17kD, B17) |
AF035840 | 109646 | NDUFB6 | 1.002 | 0.96713 |
670 | 0015078 | hydrogen ion transporter activity | H001573_01 | NADH dehydrogenase (ubiquinone) flavoprotein 2 (24kD) | M22538 | 51299 | NDUFV2 | 0.983 | 0.71504 |
671 | 0015078 | hydrogen ion transporter activity | H001574_01 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 (16kD, SGDH) |
AF047181 | 19236 | NDUFB5 | 0.918 | 0.15934 |
672 | 0015078 | hydrogen ion transporter activity | H001576_01 | NADH dehydrogenase (ubiquinone) Fe-S protein 2 (49kD) (NADH-coenzyme Q reductase) |
AF050640 | 173611 | NDUFS2 | 0.902 | 0.11184 |
673 | 0015078 | hydrogen ion transporter activity | H000185_01 | ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
X63422 | 89761 | ATP5D | 1.029 | 0.72891 |
674 | 0015078 | hydrogen ion transporter activity | H001580_01 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 (39kD) | L04490 | 75227 | NDUFA9 | 0.979 | 0.66969 |
675 | 0015078 | hydrogen ion transporter activity | H002007_01 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1, cardiac muscle |
D14710 | 155101 | ATP5A1 | 0.963 | 0.52195 |
676 | 0015078 | hydrogen ion transporter activity | H002282_01 | NADH dehydrogenase (ubiquinone) flavoprotein 1 (51kD) | AF053070 | 7744 | NDUFV1 | 1.092 | 0.11392 |
677 | 0015078 | hydrogen ion transporter activity | H003085_01 | NADH dehydrogenase (ubiquinone) Fe-S protein 6 (13kD) (NADH-coenzyme Q reductase) |
AF044959 | 49767 | NDUFS6 | 1.006 | 0.88765 |
678 | 0015078 | hydrogen ion transporter activity | H003132_01 | Nicotinamide nucleotide transhydrogenase | U40490 | 18136 | NNT | 0.917 | 0.25595 |
679 | 0015078 | hydrogen ion transporter activity | H000388_01 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6 |
AL110183 | 73851 | ATP5J | 1.045 | 0.27907 |
680 | 0015078 | hydrogen ion transporter activity | H004736_01 | Cytochrome c oxidase subunit VIIb | Z14244 | 75752 | COX7B | 1.06 | 0.26006 |
681 | 0015078 | hydrogen ion transporter activity | H005548_01 | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferrin |
X83218 | 76572 | ATP5O | 1.045 | 0.37569 |
682 | 0015078 | hydrogen ion transporter activity | H005788_01 | Vacuolar proton pump delta polypeptide | NM_015994 | 272630 | VATD | 0.851 | 0.06815 |
683 | 0015078 | hydrogen ion transporter activity | H005994_01 | ATPase, H+ transporting, lysosomal (vacuolar proton pump), beta polypeptide, 56/58kD, isoform 2 |
L35249 | 1697 | ATP6B2 | 0.927 | 0.20852 |
684 | 0015078 | hydrogen ion transporter activity | H006153_01 | ATPase, vacuolar, 14 kD | D49400 | 78089 | ATP6S14 | 1.02 | 0.7878 |
685 | 0015078 | hydrogen ion transporter activity | H006240_01 | Solute carrier family 9 (sodium/hydrogen exchanger), isoform 5 | AF111173 | 198295 | SLC9A5 | 1.092 | 0.21488 |
686 | 0015078 | hydrogen ion transporter activity | H006293_01 | ATPase, H+ transporting, lysosomal (vacuolar proton pump) 21kD | D89052 | 7476 | ATP6F | 0.919 | 0.12836 |
687 | 0015078 | hydrogen ion transporter activity | H006320_01 | ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 |
D16562 | 155433 | ATP5C1 | 1.036 | 0.56223 |
688 | 0015078 | hydrogen ion transporter activity | H006566_01 | Surfeit 1 | Z35093 | 3196 | SURF1 | 1.012 | 0.78851 |
689 | 0015078 | hydrogen ion transporter activity | H007321_01 | Cytochrome c oxidase subunit Va | M22760 | 181028 | COX5A | 1.029 | 0.61125 |
690 | 0015078 | hydrogen ion transporter activity | H007339_01 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit e |
D50371 | 85539 | ATP5I | 1.09 | 0.05197 |
691 | 0015078 | hydrogen ion transporter activity | H000596_01 | T-cell, immune regulator 1 | U45285 | 46465 | TCIRG1 | 1.007 | 0.89507 |
692 | 0015078 | hydrogen ion transporter activity | H007379_01 | Ubiquinol-cytochrome c reductase core protein I | L16842 | 119251 | UQCRC1 | 1.088 | 0.08601 |
693 | 0015078 | hydrogen ion transporter activity | H007828_01 | ATP synthase, H+ transporting, mitochondrial F1F0, subunit d | AF087135 | 64593 | ATP5JD | 1.048 | 0.29166 |
694 | 0015078 | hydrogen ion transporter activity | H008257_01 | CGI-11 protein | NM_015941 | 19575 | LOC51606 | 0.916 | 0.08209 |
695 | 0015078 | hydrogen ion transporter activity | H008343_01 | ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit |
NM_006886 | 177530 | ATP5E | 0.937 | 0.20022 |
696 | 0015078 | hydrogen ion transporter activity | H008594_01 | CGI-39 protein; cell death-regulatory protein GRIM19 | NM_015965 | 279574 | LOC51079 | 0.951 | 0.32588 |
697 | 0015078 | hydrogen ion transporter activity | H008752_01 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 8 (RNA helicase) | D50487 | 171872 | DDX8 | 1.107 | 0.13986 |
698 | 0015078 | hydrogen ion transporter activity | H009190_01 | ATPase, H+ transporting, lysosomal (vacuolar proton pump) 31kD | X76228 | 77805 | ATP6E | 0.882 | 0.09289 |
699 | 0015078 | hydrogen ion transporter activity | H009563_01 | Ubiquinol-cytochrome c reductase binding protein | M22348 | 131255 | UQCRB | 1.046 | 0.28769 |
700 | 0015078 | hydrogen ion transporter activity | H009699_01 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c (subunit 9) isoform 3 |
U09813 | 429 | ATP5G3 | 1.077 | 0.21392 |
701 | 0015078 | hydrogen ion transporter activity | H010384_01 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 (19kD, PGIV) |
NM_014222 | 31547 | NDUFA8 | 0.984 | 0.70072 |
702 | 0015078 | hydrogen ion transporter activity | H000765_01 | Cytochrome b-5 | M22976 | 83834 | CYB5 | 0.82 | 0.01254 |
703 | 0015078 | hydrogen ion transporter activity | H010491_01 | Cytochrome c oxidase subunit VIIa polypeptide 2 like | AB007618 | 30888 | COX7A2L | 1.109 | 0.09893 |
704 | 0015078 | hydrogen ion transporter activity | H010619_01 | Ubiquinol-cytochrome c reductase core protein II | J04973 | 173554 | UQCRC2 | 0.977 | 0.62446 |
705 | 0015078 | hydrogen ion transporter activity | H010932_01 | ATP synthase, H+ transporting, mitochondrial F1F0, subunit g | AL050277 | 107476 | ATP5JG | 1.071 | 0.142 |
706 | 0015078 | hydrogen ion transporter activity | H010960_01 | ATPase, H+ transporting, lysosomal (vacuolar proton pump) 9kD | Y15286 | 24322 | ATP6H | 0.879 | 0.02487 |
707 | 0015078 | hydrogen ion transporter activity | H011203_01 | Solute carrier family 9 (sodium/hydrogen exchanger), isoform 6 | AF030409 | 62185 | SLC9A6 | 1.012 | 0.79956 |
708 | 0015078 | hydrogen ion transporter activity | H011537_01 | COX11 (yeast) homolog, cytochrome c oxidase assembly protein | AF044321 | 241515 | COX11 | 0.976 | 0.7547 |
709 | 0015078 | hydrogen ion transporter activity | H011753_01 | ATPase, H+ transporting, lysosomal (vacuolar proton pump) 42kD | AK000064 | 86905 | ATP6C | 1.003 | 0.97556 |
710 | 0015078 | hydrogen ion transporter activity | H000085_01 | Cytochrome c oxidase subunit VIb | X13923 | 174031 | COX6B | 0.988 | 0.76171 |
711 | 0015078 | hydrogen ion transporter activity | H012749_01 | NADH dehydrogenase (ubiquinone) Fe-S protein 8 (23kD) (NADH-coenzyme Q reductase) |
AK002110 | 90443 | NDUFS8 | 1.109 | 0.16723 |
712 | 0015078 | hydrogen ion transporter activity | H013186_01 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 (22kD, B22) |
NM_005005 | 15977 | NDUFB9 | 1.048 | 0.32858 |
713 | 0015078 | hydrogen ion transporter activity | H001053_01 | Solute carrier family 9 (sodium/hydrogen exchanger), isoform 1 (antiporter, Na+/H+, amiloride |
S68616 | 170222 | SLC9A1 | 0.96 | 0.34393 |
714 | 0015078 | hydrogen ion transporter activity | H015293_01 | Ubiquinol-cytochrome c reductase complex (7.2 kD) | NM_013387 | 284292 | HSPC051 | 1.078 | 0.13086 |
715 | 0015078 | hydrogen ion transporter activity | H001069_01 | ATPase, H+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 1A (110/11 |
Z71460 | 267871 | ATP6N1A | 0.876 | 0.02946 |
716 | 0015078 | hydrogen ion transporter activity | H001097_01 | Solute carrier family 9 (sodium/hydrogen exchanger), isoform 3 | U28043 | 123044 | SLC9A3 | 0.903 | 0.1196 |
717 | 0015078 | hydrogen ion transporter activity | H015976_01 | Homo sapiens clone 023e08 My032 protein mRNA, complete cds | AF061735 | 307099 | 1.028 | 0.60769 | |
718 | 0015078 | hydrogen ion transporter activity | H016294_01 | Cytochrome c oxidase subunit VIIc | NM_001867 | 3462 | COX7C | 1.009 | 0.84276 |
719 | 0015078 | hydrogen ion transporter activity | H016310_01 | Low molecular mass ubiquinone-binding protein (9.5kD) | NM_014402 | 3709 | QP-C | 1.058 | 0.19398 |
720 | 0015078 | hydrogen ion transporter activity | H016350_01 | 13kDa differentiation-associated protein | NM_018838 | 44163 | LOC55967 | 1.189 | 0.00368 |
721 | 0015078 | hydrogen ion transporter activity | H016396_01 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 (9kD, MLRQ) |
NM_002489 | 50098 | NDUFA4 | 0.92 | 0.16861 |
722 | 0015078 | hydrogen ion transporter activity | H016552_01 | Ubiquinol-cytochrome c reductase (6.4kD) subunit | NM_006830 | 8372 | UQCR | 1.005 | 0.92218 |
723 | 0015078 | hydrogen ion transporter activity | H000121_01 | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
D00022 | 25 | ATP5B | 1.07 | 0.30166 |
724 | 0015078 | hydrogen ion transporter activity | H000125_01 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1 |
X60221 | 81634 | ATP5F1 | 1.008 | 0.90231 |
725 | 0015078 | hydrogen ion transporter activity | H001301_01 | Activating transcription factor 7 | X52943 | 55888 | ATF7 | 0.926 | 0.12647 |